DSS (DSS) 10-K 31 Mar 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Mar. 20, 2020	Jun. 30, 2019
Document And Entity Information
Entity Registrant Name	DOCUMENT SECURITY SYSTEMS INC
Entity Central Index Key	0000771999
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 11,583,641
Entity Common Stock, Shares Outstanding		62,086,099
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash	$ 1,096,248	$ 2,447,985
Accounts receivable, net of $41,000 and $50,000 respectively allowance for doubtful accounts	4,211,906	2,217,877
Inventory	1,707,690	1,563,593
Prepaid expenses and other current assets	459,868	285,580
Total current assets	7,475,712	6,515,035
Property, plant and equipment, net	5,060,698	5,014,494
Investment	2,154,175	324,930
Notes receivable	793,195
Other assets	49,875	90,319
Right-of-use assets	1,222,742
Goodwill	2,453,597	2,453,597
Other intangible assets, net	934,765	881,411
Total assets	20,144,759	15,279,786
Current liabilities:
Accounts payable	1,492,494	1,347,491
Accrued expenses and deferred revenue	935,041	1,106,346
Other current liabilities	390,494	2,255,942
Revolving line of credit	500,000
Current portion of lease liability	397,097
Current portion of long-term debt, net	440,699	713,427
Total current liabilities	4,155,825	5,423,206
Long-term debt, net	2,309,847	1,721,936
Long term lease liability	825,645
Other long-term liabilities	507,058	391,325
Deferred tax liability, net	43,567	168,986
Commitments and contingencies (Note 13)
Stockholders' equity
Common stock, $.02 par value; 200,000,000 shares authorized, 36,180,626 shares issued and outstanding (17,425,858 on December 31, 2018)	723,612	348,517
Additional paid-in capital	114,860,150	107,624,666
Accumulated other comprehensive loss		(7,052)
Accumulated deficit	(103,280,945)	(100,391,798)
Total stockholders' equity	12,302,817	7,574,333
Total liabilities and stockholders' equity	$ 20,144,759	$ 15,279,786

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts, accounts receivable	$ 41,000	$ 50,000
Common stock, par value	$ .02	$ .02
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	36,180,626	17,425,858
Common stock, shares outstanding	36,180,626	17,425,858

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue:
Total revenue	$ 19,409,230	$ 18,515,082
Costs and expenses:
Cost of revenue, exclusive of depreciation and amortization	12,602,494	11,853,499
Selling, general and administrative (including stock based compensation)	8,283,266	7,088,610
Depreciation and amortization	1,403,836	1,281,634
Total costs and expenses	22,289,596	20,223,743
Operating loss	(2,880,366)	(1,708,661)
Other income (expense):
Interest income	24,953	8,634
Interest expense	(157,319)	(144,819)
Amortization of deferred financing costs and debt discount	(1,901)	(46,251)
Impairment of investment		(160,000)
Gain on extinguishment of liabilities, net		3,532,659
Income (loss) before income taxes	(3,014,634)	1,481,562
Income tax expense (benefit)	(125,487)	16,593
Net income (loss)	(2,889,147)	1,464,969
Other comprehensive income (loss):
Interest rate swap (loss)	(15,431)	16,017
Settlement of Interest rate swap	22,483
Comprehensive income (loss):	$ (2,882,095)	$ 1,480,986
Income (loss) per common share:
Basic	$ (0.11)	$ 0.09
Diluted	$ (0.11)	$ 0.09
Shares used in computing income (loss) per common share:
Basic	25,505,404	16,724,376
Diluted	25,505,404	16,930,805
Printed Products [Member]
Revenue:
Total revenue	$ 17,089,740	$ 16,940,262
Technology Sales, Services and Licensing [Member]
Revenue:
Total revenue	2,147,740	1,574,820
Direct Selling [Member]
Revenue:
Total revenue	$ 171,750

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ (2,889,147)	$ 1,464,969
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization	1,403,836	1,281,634
Stock based compensation	421,673	131,733
Paid in-kind interest		12,000
Change in deferred tax provision	(125,419)	9,673
Amortization of deferred financing costs and debt discount	1,901	46,251
Gain on extinguishment of liabilities, net		(3,532,659)
Impairment of investment		160,000
Decrease (increase) in assets:
Accounts receivable	(1,994,029)	(192,593)
Inventory	(144,097)	87,653
Prepaid expenses and other assets	(133,844)	(31,198)
Increase (decrease) in liabilities:
Accounts payable	145,003	618,836
Accrued expenses	(279,036)	(113,793)
Other liabilities	(1,749,715)	(1,325,427)
Net cash used by operating activities	(5,342,874)	(1,382,921)
Cash flows from investing activities:
Purchase of property, plant and equipment	(988,876)	(1,003,413)
Purchase of investment	(1,829,245)
Issuance of notes receivable	(793,195)
Purchase of intangible assets	(369,735)	(100,138)
Net cash used by investing activities	(3,981,051)	(1,103,551)
Cash flows from financing activities:
Payments of long-term debt	(274,468)	(1,188,081)
Borrowings from lines of credit, net	587,750	502,155
Borrowings from revolving lines of credit, net	500,000
Borrowings from conversion of note	500,000
Issuances of common stock, net of issuance costs	6,658,906	887,755
Receipt of subscription receivable, net of issuance costs		288,000
Net cash provided by financing activities	7,972,188	489,829
Net decrease in cash	(1,351,737)	(1,996,643)
Cash and cash equivalents at beginning of year	2,447,985	4,444,628
Cash and cash equivalents at end of year	$ 1,096,248	$ 2,447,985

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017	$ 331,987	$ 106,633,708	$ (300,000)	$ (23,069)	$ (101,856,767)	$ 4,785,859
Balance, shares at Dec. 31, 2017	16,599,327
Issuance of common stock, net	$ 16,530	859,225	300,000			1,175,755
Issuance of common stock, net, shares	826,531
Stock based payments, net of tax effect		131,733				131,733
Stock based payments, net of tax effect, shares
Other comprehensive gain (loss)				16,017		16,017
Net income					1,464,969	1,464,969
Balance at Dec. 31, 2018	$ 348,517	107,624,666		(7,052)	(100,391,798)	7,574,333
Balance, shares at Dec. 31, 2018	17,425,858
Issuance of common stock, net	$ 365,921	6,937,768				7,303,689
Issuance of common stock, net, shares	18,296,049
Stock based payments, net of tax effect	$ 9,174	297,716				306,890
Stock based payments, net of tax effect, shares	458,719
Other comprehensive gain (loss)				7,052		7,052
Net income					(2,889,147)	(2,889,147)
Balance at Dec. 31, 2019	$ 723,612	$ 114,860,150			$ (103,280,945)	$ 12,302,817
Balance, shares at Dec. 31, 2019	36,180,626

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	NOTE 1 - DESCRIPTION OF BUSINESS Document Security Systems, Inc. (the “Company”), through two of its subsidiaries, Premier Packaging Corporation, which operates under the assumed name of DSS Packaging Group, and Plastic Printing Professionals, Inc., which operates under the name of DSS Plastics Group, operates in the security and commercial printing, packaging and plastic ID markets. The Company develops, markets, manufactures and sells paper and plastic products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. The Company’s subsidiary, DSS Digital Inc., which also operates under the name of DSS Digital Group, researches, develops, markets and sells worldwide the Company’s digital products, including and primarily our AuthentiGuard® product, which is a brand authentication application that integrates the Company’s counterfeit deterrent technologies with proprietary digital data security-based solutions. The Company’s subsidiary, DSS Technology Management (“DSSTM”), Inc., manages, licenses and acquires intellectual property (“IP”) assets for the purpose of monetizing these assets through a variety of value-enhancing initiatives, including, but not limited to, investments in the development and commercialization of patented technologies, licensing, strategic partnerships and commercial litigation. In 2018, the Company commenced operations in the Asia Pacific market through its subsidiary DSS Asia Limited, which was formed in 2017. In 2019, DSS created four new, wholly owned subsidiaries all of which currently have no employees and are in the exploratory stage and looking for opportunities. DSS Blockchain Security, Inc., that intends to specialize in the development of blockchain security technologies for tracking and tracing solutions for supply chain logistics and cyber securities across global markets. Decentralize Sharing Systems, Inc., that amongst other things, intends to provide services to assist companies utilizing blockchain technologies for sharing system solutions in the new economics of the peer-to-peer decentralized sharing marketplaces. DSS Securities, Inc., anticipates establishing or acquiring two parallel streams of digital asset exchanges in multiple jurisdictions: (i) securitized token exchanges, focusing on digitized assets from different vertical industries and (ii) utilities token exchanges, focusing on “blue-chip” utility tokens from solid businesses. DSS BioHealth Security, Inc., to invest in companies that include, but not limited to, holding bio-medical intellectual property and/or which have, or are securing, strategic alliances, partnerships and distributing rights for biomedical and security products, technologies or enterprises. This new division will focus on open-air defense initiatives, which curb transmission of air-borne infectious diseases such as tuberculosis, influenza, among others, in open areas.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation Use of Estimates Reclassifications Cash Equivalents - Accounts Receivable Inventory Property, Plant and Equipment Investment Goodwill - Other Intangible Assets and Patent Application Costs Impairment of Long-Lived Assets Fair Value of Financial Instruments ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts reported in the balance sheet of cash and cash equivalents, accounts receivable, prepaids, accounts payable and accrued expenses approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair value of notes receivable approximates their carrying value as the stated or discounted rates of the notes do not reflect recent market conditions. The fair value of revolving credit lines notes payable and long-term debt approximates their carrying value as the stated or discounted rates of the debt reflect recent market conditions. Derivative instruments, as discussed below, are recorded as assets and liabilities at estimated fair value based on available market information. The fair value of investments carried at cost less impairment; however, the fair value is not considered readily determinable based on the lack of liquidity for the shares owned. Derivative Instruments Share-Based Payments Revenue Recognition The Company sells printed products including packaging printing and fabrication, commercial and security printing and plastic cards and badges, including cards and badges integrated with technology such as RFID and smart chips. The Company also provides information technology services and digital authentication products and services to its customers. The Company recognizes its products and services revenue based on when the title passes to the customer or when the service is completed and accepted by the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for shipped product or service provided. Sales and other taxes billed and collected from customers are excluded from revenue. Customers, including distributors, do not have a general right of return. The Company also derives revenue from royalties from third parties which are typically based on licensees’ net sales of products that utilize the Company’s technology, or on a per item usage of the technology on the customers’ printed products. The Company recognizes license revenue at the time it is reported by the licensee. From time to time, the Company generates license revenues through litigation settlements. For these, the Company recognizes revenue upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met. As of December 31, 2019, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to Topic 606, the Company has applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. The Company elected the practical expedient allowing it to not recognize as a contract asset the commission paid to its salesforce on the sale of its products as an incremental cost of obtaining a contract with a customer but rather recognize such commission as expense when incurred as the amortization period of the asset that the Company would have otherwise recognized is one year or less. Sales Commissions Sales commissions are expensed as incurred for contracts with an expected duration of one year or less. There were no sales commissions capitalized as of December 31, 2019. Shipping and Handling Costs Costs incurred by the Company related to shipping and handling are included in cost of products sold. Amounts charged to customers pertaining to these costs are reflected as revenue. Costs of revenue - Contingent Legal Expenses - Advertising Costs . Research and Development the Company’s AuthentiGuard product line Income Taxes Earnings Per Common Share As of December 31, 2019, and 2018, there were 1,798,221 and 2,212,773, respectively, of common stock share equivalents potentially issuable under options, warrants, and restricted stock agreements that could potentially dilute basic earnings per share in the future. For the twelve-months ended December 31, 2019, equivalents were excluded from the calculation of diluted earnings per share since their inclusion would have been anti-dilutive. For the twelve-months ended December 31, 2018, based on the average market price of the Company’s common stock during that period of $1.27, 206,429 common stock equivalents were added to the basic shares outstanding to calculate dilutive earnings per share. Comprehensive Income (Loss) Concentration of Credit Risk During 2019, two customers accounted for 45% of our consolidated revenue. As of December 31, 2019, these two customers accounted for 49% of our consolidated trade accounts receivable balance. As of December 31, 2018, these two customers accounted for 44% of our consolidated revenue and 38% of our consolidated trade accounts receivable balance. Continuing Operations and Going Concern – The expected use of cash for operations in 2020 will be primarily for funding operating losses, working capital, legal expenses associated with intellectual property related litigation, and the costs associated with the global roll-out of the Company’s AuthentiGuard product line. The Company will also use these funds to make capital improvements at its two manufacturing facilities to increase production capacity and create efficiencies, as well as to diversify its revenue streams and take advantage of profit opportunities. The Company’s management intends to take actions necessary to continue as a going concern. Management’s plans concerning these matters includes, among other things, continued growth among our operating segments including international expansion of our AuthentiGuard product, and tightly controlling operating costs and reducing spending growth rates wherever possible to return to profitability. We believe that our $1.1 million in aggregate cash and equivalents as of December 31, 2019 as well as the $4.0 million raised on February 25, 2020 will allow us to fund our four operating segments current and planned operations through March 2021. Based on this, we have concluded that substantial doubt of our ability to continue as a going concern has been alleviated. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02 and its related amendments which introduced Leases (Topic 842, or “ASC 842”), a new comprehensive lease accounting model that supersedes the current lease guidance under Leases (Topic 840). The new accounting standard requires lessees to recognize right-of-use (“ROU”) assets and corresponding lease liabilities for all leases with lease terms of greater than 12 months. It also changes the definition of a lease and expands the disclosure requirements of lease arrangements. In July 2018, the FASB added a transition option for implementation that allows companies to continue to use the legacy guidance in ASC 840, Leases, including its disclosure requirements, in the comparative periods presented in the year of adoption. The Company adopted the guidance effective January 1, 2019. The Company elected the transition package of three practical expedients permitted under the transition guidance and elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption, without a restatement of prior periods. Further, the Company elected a short-term lease exception policy, permitting the Company to not apply the recognition requirements of this standard to short-term leases (i.e. leases with terms of 12 months or less). As a result of the adoption, the Company adjusted its beginning balance as of January 1, 2019 by recording operating lease ROU asset and liabilities through a cumulative-effect adjustment. The adoption impacted the accompanying consolidated balance sheet, but did not have an impact on the consolidated statements of operations and comprehensive income (loss). At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company calculates the associated lease liability and corresponding ROU assets upon lease commencement using a discount rate based on a credit adjusted secured borrowing rate commensurate with the term of the lease. The Company records lease liabilities within current or noncurrent liabilities based upon the length of time associated with the lease payments. The operating lease ROU assets includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any, and are recorded as noncurrent assets. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with an initial term of 12 months or less are not recorded on the accompanying consolidated balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The impact of the adoption of ASC 842 on the accompanying consolidated balance sheet as of January 1, 2019 was a right-of-use asset and a lease liability of approximately $1,443,800. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments-Credit Losses (Topic 326)”, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently assessing the impact that adopting this new accounting standard will have on our consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment”, which eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. The annual assessment of goodwill impairment will be determined by using the difference between the carrying amount and the fair value of the reporting unit. The standards update is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently assessing the impact that adopting this new accounting standard will have on its Consolidated Financial Statements and plans to adopt ASU 2017-04 in the first quarter of 2020.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Inventory	NOTE 3 – INVENTORY Inventory consisted of the following at December 31: 2019 2018 Finished Goods $ 1,097,616 $ 1,144,695 Work in Process 246,159 339,091 Raw Materials 363,915 79,807 $ 1,707,690 $ 1,563,593

Notes Receivable

Notes Receivable	12 Months Ended
	Dec. 31, 2019
Notes Receivable
Notes Receivable	NOTE 4 – NOTES RECEIVABLE On October 10, 2019, the Company entered into a convertible promissory note (“Note”) with Century TBD Holdings, LLC (“TBD”), a Florida limited liability company. The Company loaned the principal sum of $500,000, of which up to $500,000 and all accrued interest can be paid by an “Optional Conversion” of such amount up to 19.8% (non-dilutable) of all outstanding membership interest in TBD. This Note accrues interest at 6% and matures on October 9, 2021. As of December 31, 2019, this Note had outstanding principle and interest of $506,756. On October 9, 2019 and November 11, 2019 the Company entered into two, separate on demand, convertible notes (“Note” or “Notes”) with RBC Life Sciences, Inc. (RBC), a Nevada corporation. The first Note, dated October 9 th th

Investment

Investment	12 Months Ended
	Dec. 31, 2019
Investments in and Advances to Affiliates [Abstract]
Investment	NOTE 5 - INVESTMENT As of December 31, 2018, the Company owned 21,196,552 ordinary shares and an existing three-year warrant to purchase up to 105,982,759 ordinary shares at an exercise price of SGD$0.040 (US$0.0298) per share of Singapore eDevelopment Limited (“SED”), a company incorporated in Singapore and publicly listed on the Singapore Exchange Limited. The restriction on the sale of shares, and execution of the warrants expired on September 17, 2019. At the time of the investment, the cost of the investment was determined to be the fair value of the Company’s common stock issued in the transaction, which was determined to have the most readily determinable fair value. In 2018, the Company adopted ASU No. 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities.” has and carries its investment in SED at costs. During the 4th quarter of 2018, the Company determined that its investment in Singapore eDevelopment (“SED”) was impaired due to the decline in the share price of SED, especially since November of 2018, which the Company believes was influenced by a general decline in equity markets in Asia caused by the tariff dispute between the United States and China. As such, in response to the decline in the trading value of the SED shares in the fourth quarter of 2018, the Company performed an impairment test and determined an impairment of approximately $160,000 was warranted. Similar analysis was performed at December 31, 2019 and no further impairment is deemed necessary as the stock price has rebounded in excess of 15%. The carrying value of the initial 21,196,552 ordinary shares investment as of December 31, 2019 was $324,930. On December 19, 2019, the Company exercised the warrant, in part, pursuant to which the Company acquired 61,977,577 ordinary shares of SED. The total consideration paid by the Company for these ordinary shares was SGD$2,479,103.08, or approximately $1,833,000 USD, the investment value at December 31, 2019. After giving effect to the warrant exercise, the Company now owns 83,174,129 ordinary shares of SED, representing approximately 7.1% of the outstanding shares of SED, and the remaining warrant to purchase 44,005,182 ordinary shares of SED. The Chairman of the Company, Mr. Heng Fai Ambrose Chan, is the Executive Director and Chief Executive Officer of SED.

Property Plant and Equipment

Property Plant and Equipment	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	NOTE 6 - PROPERTY PLANT AND EQUIPMENT Property, plant and equipment consisted of the following at December 31: Estimated 2019 2018 Machinery and equipment 5-10 years 8,567,911 7,723,763 Building and improvements 39 years 1,961,544 1,923,027 Land 185,000 185,000 Leasehold improvements 3-10 years 776,674 760,286 Furniture and fixtures 7 years 109,862 94,364 Software and websites 3 years 298,797 187,511 Total Cost 11,899,788 10,873,951 Less accumulated depreciation 6,839,090 5,859,457 Property, plant and equipment, net 5,060,698 5,014,494

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 7 - INTANGIBLE ASSETS During 2019 and 2018, the Company spent approximately $10,000 and $20,000, respectively, on capitalized patent application costs. On June 26, 2018, the Company entered into an agreement with Fortress Credit Co LLC (“Fortress”), which among other things transferred to Fortress all of the remaining economic rights to certain of the Company’s semi-conductor related patents (See Note 8). As a result, the Company wrote-off these patents which had an aggregated gross cost of $2,655,000 and a net unamortized carrying amount of $295,470 on the agreement date. On July 31, 2018, the Company entered into a Non-Compete Letter Agreement (the “Agreement”) with its former President and Chief Executive Officer of its wholly owned subsidiary, Premier Packaging Corporation. The Agreement called for payments of $16,000 per month, for a period of 19 months, as consideration for the two-year non-competition and non-solicitation restrictive covenants. The Company recorded the aggregate cost of the Agreement of $304,000 as an intangible asset to be amortized over the 24-month period commencing August 1, 2018. On October 24, 2018, the Company’s subsidiary, DSS Asia Limited acquired Guangzhou Hotapps Technology Ltd., (“Guangzhou Hotapps”) a Chinese company, in exchange for a 2-year, $100,000 unsecured promissory note. In connection with this acquisition, the Company acquired the license to do business in China to which the Company allocated a value of $85,734 as well as a related deferred tax liability of $33,333 due to outside basis differences and recorded as an intangible asset that it will amortize over a five-year period. On March 5, 2019, the Company paid $350,000 and issued 130,435 shares of the Company’s common stock valued at $144,783 in conjunction with the signing of a Master Distributor Agreement with Advanced Cyber Security Corp. (“ACS”) for the Company to distribute ACS’s EndpointLockV™ cyber security software exclusively in thirteen countries in Asia and Australia, and non-exclusively, in the U.S. and Middle East. The aggregate cost of $494,783 of the agreement was recorded as an intangible asset to be amortized over the expected useful life of 36 months. Intangible assets are comprised of the following: 2019 2018 Useful Gross Accumulated Net Gross Accumulated Net Acquired intangibles customer lists, licenses and non-compete agreements 2-10 years 1,788,699 1,202,832 585,867 1,284,065 823,884 460,181 Acquired intangibles patents and patent rights 500,000 500,000 - 500,000 500,000 - Patent application costs Varied (1) 1,178,176 829,278 348,898 1,168,155 746,925 421,230 3,466,875 2,532,110 934,765 2,952,220 2,070,809 881,411 (1) Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2019, the weighted average remaining useful life of these assets in service was approximately 6.9 years. Amortization expense for the year ended December 31, 2019 amounted to approximately $461,000 ($487,000 –2018). Expected amortization for each of the five succeeding fiscal years is as follows: Year Amount 2020 383,276 2021 273,626 2022 127,408 2023 39,378 2024 19,112

Short Term and Long-Term Debt

Short Term and Long-Term Debt	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Short Term and Long-Term Debt	NOTE 8 – SHORT TERM AND LONG-TERM DEBT Revolving Credit Lines On July 26, 2017, Premier Packaging entered into a Loan Agreement and accompanying Term Note Non-Revolving Line of Credit Agreement with Citizens pursuant to which Citizens agreed to lend up to $1,200,000 to permit Premier Packaging to purchase equipment from time to time that it may need for use in its business. The aggregate principal balance outstanding under the Equipment Acquisition Line of Credit shall bear interest thereon at a per annum rate of 2% above the LIBOR Advantage Rate until the Conversion Date (as defined in the Term Note Non-Revolving Line of Credit). Effective on the Conversion Date, the interest shall be adjusted to a fixed rate equal to 2% above the bank’s Cost of Funds, as determined by Citizens. Current maturities of long-term debt are based on an estimated 48-month amortization which will be adjusted upon conversion. As of December 31, 2019, the line had not yet converted into a credit facility and had a balance of $898,762 ($339,000 at December 31, 2018). The Company pays a monthly amount of $12,756 in principal and interest. On December 1, 2017, the Company’s subsidiary Plastic Printing Professionals entered into a Loan Agreement and accompanying Term Note Non-Revolving Line of Credit Agreement with Citizens pursuant to which Citizens agreed to lend up to $800,000 to enable Plastic Printing Professionals to purchase equipment from time to time that it may need for use in its business. Advances may be made under this Equipment Acquisition Line of Credit, from time to time, from December 1, 2017 until December 1, 2018. The aggregate principal balance outstanding under the Equipment Acquisition Line of Credit bore interest at 2% above the LIBOR Advantage Rate (as defined in the agreement) until it was converted. Commencing March 30, 2019, the line was converted into two term notes under which the Company will make monthly payments of $13,657 until November 30, 2023. Interest under the term notes is payable monthly at 5.37%. As of December 31, 2019, the combined balance of the term notes was $576,946 ($684,554 at December 31, 2018). Term Loan Debt Promissory Notes On December 6, 2013, Premier Packaging entered into a Construction to Permanent Loan with Citizens Bank for up to $450,000 that was converted into a promissory note upon the completion and acceptance of building improvements to the Company’s packaging plant in Victor, New York. In May 2014, the Company converted the loan into a $450,000 note payable in monthly installments over a 5-year period of $2,500 plus interest calculated at a variable rate of 1 Month LIBOR plus 3.15%. The note was set to mature in July 2019 at which time a balloon payment of the remaining principal balance of $300,000 was due. On June 27, 2019 the balloon payment, in conjunction with the remaining balance on promissory note identified above, was refinanced. On June 27, 2019 Premier Packaging refinanced and consolidated the outstanding principal associated with the two promissory notes for its packaging plant located in Victor, New York, for $1,156,742 with Citizens Bank. The new Promissory Note calls for monthly payments of $7,181, with interest fixed at 4.22%. The new Promissory Note matures on June 27, 2029, at which time a balloon payment of $707,689 is due. As of December 31, 2019, the new, consolidated Promissory Note had a balance of $1,141,487. At December 31, 2018, the two refinanced notes had outstanding balances of $869,865 and $315,000. The Citizens credit facilities to each of the Company’s subsidiaries, Premier Packaging and Plastic Printing Professionals, contain various covenants including fixed charge coverage ratio, tangible net worth and current ratio covenants which are tested annually at December 31. For the year ended December 31, 2019, Premier Packaging was in compliance with the annual covenants, however Plastic Printing Professionals was not. Plastic Printing Professionals has sought and received a one-time waiver from compliance from Citizens for this violation. On October 24, 2018, the Company’s subsidiary, DSS Asia Limited entered into a $100,000 unsecured promissory note with HotApps International Pte Ltd in conjunction with the acquisition of Guangzhou Hotapps Technology Ltd., a Chinese subsidiary of HotApps International Pte Ltd, by DSS Asia Limited. The promissory note does not accrue interest and is payable in full on October 24, 2020. Effective on February 18, 2019, Document Security Systems, Inc. entered into a Convertible Promissory Note (the “Note”) with LiquidValue Development Pte Ltd (the “Holder”) in the principal sum of $500,000 (the “Principal Amount”), of which up to $500,000 of the Principal Amount can be paid by the conversion of such amount into the Company’s common stock, par value $0.02 per share, up to a maximum of 446,428 shares of common stock (the “Common Stock”), at a conversion price of $1.12 per share. The Holder is a related party, owned by one of the Company’s directors. The Note carried a fixed interest rate of 8% per annum and had a term of 12- months. Accrued interest was payable in cash in arrears on the last day of each calendar quarter, with the first interest payment due on June 30, 2019, and remained payable until the Principal Amount was paid in full. The Holder is a related party, owned by one of the Company’s directors. Effective on March 25, 2019, the Holder exercised its conversion option and converted the Maximum Conversion Amount under the Note. As a result of Holder’s election to exercise its full conversion rights under the Note, the Note was cancelled effective on March 25, 2019. Effective on May 31, 2019, Document Security Systems, Inc. (the “Company” or “Borrower”) entered into a Promissory Note (the “Note”) with LiquidValue Development Pte Ltd (the “Holder”) in the principal sum of $650,000 (the “Principal Amount”). The Note was not interest bearing with a maturity date of July 31, 2019. The Holder is a related party, owned by one of the Company’s directors. This Note was paid in full on June 12, 2019. A summary of scheduled principal payments of long-term debt, not including revolving lines of credit and other debt which can be settled with non-monetary assets, subsequent to December 31, 2019 are as follows: Year Amount 2020 $ 440,699 2021 307,324 2022 322,160 2023 322,926 2024 185,218 Thereafter $ 1,186,387 Other Debt

Other Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Other Liabilities	NOTE 9 – OTHER LIABILITIES On November 14, 2016, the Company entered into a Proceeds Investment Agreement (the “Agreement”) with Brickell Key Investments LP (“BKI”). Pursuant to the Agreement, BKI financed an aggregate of $13,500,000 in a patent purchase and monetization program to be implemented and managed by the Company (the “Financing”). Pursuant to the Agreement. $3,000,000 of the Financing was used to cover the Company’s purchase of a portfolio of U.S. and foreign LED patents and a license from Intellectual Discovery Co., Ltd., a Korean company (collectively, the “LED Patent Portfolio”), resulting in a basis in these assets of $0. A total of $6,000,000 of the Financing was directed by BKI to attorneys to cover anticipated attorneys’ fees and out-of-pocket expenses for legal proceedings that may transpire relating to enforcement of the LED Patent Portfolio. This amount is not included in the Company’s financial statements as the Company has no control over these funds, which are segregated and escrowed in the attorneys’ trust account. In addition, on November 14, 2016, the Company received $4,500,000 of the Financing, which was required to be used by the Company to pay for the defense of Inter Partes Review or other similar proceedings that may be filed from time to time by defendants with the U.S. Patent & Trademark Office relating to the LED Patent Portfolio, with excess amounts available for general working capital needs. As of December 31, 2019, an aggregate of $780,988 is recorded as other liabilities by the Company, of which $390,494 is classified as short-term. Of this amount, the Company allocated $2,500,000 which it subsequently adjusted to $1,500,000 for the payment of estimated future Inter Partes Review costs. The Company will reduce this liability as it pays legal and other expenses related to the Inter Partes Review matters involving the LED Patent Portfolio as incurred. For this amount, the Company reduced the liability with an offset to selling, general and administrative costs by $47,500 per month from January 2017 through July 2017, $80,000 per month for the remainder of 2017 through March 2018, $86,500 per month for the remainder of 2018, and through November of 2019. As of December 31, 2019 the liability has been fully amortized. An aggregate of $955,000 was recorded as a reduction of the liability allocated to working capital in 2019. On July 8, 2013, the Company’s subsidiary, DSSTM, purchased two patents for $500,000 covering certain methods and processes related to Bluetooth devices. In conjunction with the patent purchases, DSSTM entered into a Proceed Right Agreement with certain investors pursuant to which DSSTM initially received $250,000 of a total of $750,000 which it will ultimately receive thereunder, subject to certain payment milestones, in exchange for 40% of the proceeds which it receives, if any, from the use, sale or licensing of the two patents. As of December 31, 2019 and 2018, the Company had received an aggregate of $750,000 from the investors pursuant to the agreement of which $0 was in current liabilities in the consolidated balance sheets ($476,000 as of December 31, 2018). The Company reduced the liability as it paid legal and other expenses related to its litigation involving the Bluetooth patents, for which the amount is available to be used for 50% of all such expenses.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Stockholders' Equity	NOTE 10 - STOCKHOLDERS’ EQUITY Sales of Equity On December 17, 2018, the Company sold 612,245 shares of its common stock, par value $0.02 per share, to a related party accredited investor, Heng Fai Holdings Limited. The purchase price was $0.98 per share, for total proceeds of $600,000. On February 18, 2019, the Company had entered into a Convertible Promissory Note with LiquidValue Development Pte Ltd ., a company owned and controlled by Mr. Heng Fai Ambrose Chan, DSS’s Chairman, in the principal sum of $500,000, of which up to $500,000 of the Principal Amount could be paid by the conversion of such amount into the Company’s common stock, par value $0.02 per share, up to a maximum of 446,428 shares of common stock (the “Maximum Conversion Amount”), at a conversion price of $1.12 per share. Effective on March 25, 2019, LiquidValue Development Pte Ltd exercised its conversion option and converted the Maximum Conversion Amount under the Note. (Note 8) On March 5, 2019, the Company issued 130,435 shares of its common stock at $1.15 per share as partial consideration for a licensing and distribution agreement entered into with Advanced Cyber Security Corp. (Note7) On June 5, 2019, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp., acting as representative of the several underwriters, which provided for the issuance and sale by the Company in an underwritten public offering (the “Offering”) and the purchase by the Underwriters of 11,200,000 shares of the Company’s common stock, $0.02 par value per share. Subject to the terms and conditions contained in the Underwriting Agreement, the shares were sold to the Underwriters at a public offering price of $0.50 per share, less certain underwriting discounts and commissions. As part of this transaction, 2,000,000 shares were purchased by Heng Fai Ambrose Chan, Chairman of the Board of directors. The Company also granted the Underwriters a 45-day option to purchase up to 1,680,000 additional shares of the Company’s common stock on the same terms and conditions for the purpose of covering any over-allotments in connection with the Offering (519,186 shares were exercised on July 18, 2019 at $0.50 per share, less underwriting discounts and expenses). The net offering proceeds to the Company was approximately $5.0 million, inclusive of the July 18, 2019 transaction and after deducting underwriting discounts, commissions and other offering expenses. On November 1, 2019, pursuant to a Subscription Agreement, LiquidValue Development Pte LTD, a company owned and controlled by Mr. Heng Fai Ambrose Chan, DSS’s Chairman, purchased from the Company, in a private placement, and aggregate of 6,000,000 shares of common stock, for an above market purchase price equal to $0.30 per share (at the time of LiquidValues’ commitment, the closing stock price was $0.26 per share) for net proceeds to the Company of approximately $1.6 million after deducting underwriting discounts, commissions and other offering expenses. Stock Warrants 2019 2018 Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Outstanding at January 1, 1,430,116 $ 4.00 2,645,090 $ 10.98 Granted - - - - Lapsed/terminated (209,812 ) 20.78 (1,214,974 ) 19.20 Outstanding at December 31, 1,220,304 $ 1.12 1,430,116 $ 4.00 Exercisable at December 31, 1,220,304 $ 1.12 1,430,116 $ 4.00 Weighted average of months remaining 20.7 27.9 The Company did not issue any warrants in 2019 or 2018. Stock Options On December 9, 2019, the Company’s shareholders adopted the 2020 Employee, Director and Consultant Equity Incentive Plan (the “2020 Plan”). The 2020 Plan provides for the issuance of up to a total of 7,236,125 shares of common stock authorized to be issued for grants of options, restricted stock and other forms of equity to employees, directors and consultants. Under the terms of the 2020 Plan, options granted thereunder may be designated as options which qualify for incentive stock option treatment (“ISOs”) under Section 422A of the Internal Revenue Code, or options which do not qualify (“NQSOs”). The following is a summary with respect to options outstanding at December 31, 2019 and 2018 and activity during the years then ended: 2019 2018 Number of Options Weighted Average Exercise Price Weighted Average life Remaining (Years) Number of Options Weighted Average Exercise Price Weighted Average life Remaining (Years) Outstanding at January 1, 782,655 $ 6.66 482,667 $ 10.72 Granted - - 405,000 1.38 Lapsed/terminated (204,738 ) 7.7 (105,012 ) 4.96 Outstanding at December 31, 577,917 $ 5.01 3.2 782,655 $ 6.66 3.2 Exercisable at December 31, 408,750 $ 6.50 3.5 490,988 $ 8.30 2.8 Expected to vest at December 31, 169,167 $ 1.43 3.4 291,667 $ 1.41 4.5 Aggregate intrinsic value of outstanding options at December 31, $ - $ - Aggregate intrinsic value of exercisable options at December 31, $ - $ - Aggregate intrinsic value of options expected to vest at December 31, $ - $ - During the year ended December 31, 2018, the Company issued an aggregate of 405,000 options to purchase the Company’s common stock at between $1.30 and $1.55 per share with a term of five years to employees at its technology, corporate and printed products divisions, as well as independent board members. For 265,000 options granted during 2018 the options vest pro-ratably as follows: 1/3 on the grant date, 1/3 on the first anniversary of the grant date and 1/3 on the second anniversary of the grant date. For the remaining 140,000 options granted during 2018 the options vest pro-ratably as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. The fair value of each option award is estimated on the date of grant utilizing the Black-Scholes-Merton Option Pricing Model. The Company estimates the expected volatility of the Company’s common stock at the grant date using the historical volatility of the Company’s common stock over the most recent period equal to the expected stock option term. The following table shows our weighted average assumptions used to compute the share-based compensation expense for stock options and warrants granted during the year ended December 31, 2018. There were no options or warrants granted for compensation during the year ended December 31, 2019. Volatility 98.20 % Expected option term 3.6 years Risk-free interest rate 2.7 % Expected forfeiture rate 0.0 % Expected dividend yield 0.0 % The aggregate grant date fair value of options that vested during 2019 and 2018 was approximately $104,000 and $122,000, respectivly. There were no options exercised during 2019 or 2018. Restricted Stock On September 6, 2019, the Company issued an aggregate of 224,310 shares of fully vested restricted stock to members of the Company’s management team of with a two-year lock-up period and had an aggregated grant date fair value of approximately $94,000 which is included in stock based compensation for the year ended December 31, 2019. The Company did not grant any restricted stock in 2018. Stock-Based Compensation In July 2019, by unanimous written consent, the Board of Directors authorized the Company to issue individual stock grants of the Company’s common stock, pursuant to the Company’s 2013 Employee, Director and Consultant Equity Incentive Plan, to certain officers and directors in the amount of 458,719 shares, at $0.42 per share which were immediately vested and issued on September 6, 2019. 224,310 of these shares where were fully vested restricted stock to members of the Company’s management team of with a two-year lock-up period.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 11 - INCOME TAXES Following is a summary of the components giving rise to the income tax provision (benefit) for the years ended December 31: The provision (benefit) for income taxes consists of the following: 2019 2018 Currently payable: Federal $ - $ - State (68 ) 6,920 Total currently payable (68 ) 6,920 Deferred: Federal (367,473 ) 458,446 State (124,975 ) 67,451 Foreign (116,863 ) (92,690.00 ) Total deferred (609,311 ) 433,207 Less: increase in allowance 476,972 (423,534 ) Net deferred (125,419 ) 9,673 Total income tax provision $ (125,487 ) $ 16,593 Individual components of deferred taxes are as follows: Deferred tax assets: 2019 2018 Net operating loss carry forwards $ 11,188,858 $ 10,135,005 Equity issued for services 169,445 152,240 Goodwill and other intangibles 675,885 788,288 Investment in pass-through entity 11,621 11,499 Deferred revenue 181,519 472,466 Operating Lease Liability 284,193 - Other 376,462 470,780 Gross deferred tax assets 12,887,983 12,030,278 Deferred tax liabilities: Goodwill and other intangibles 29,046 33,333 Depreciation and amortization - 31,512 Right -of-use asset 284,193 - Gross deferred tax liabilities 313,239 64,845 Less: valuation allowance (12,618,311 ) (12,134,419 ) Net deferred tax liabilities $ (43,567 ) $ (168,986 ) The 2017 Tax Cuts and Jobs Act repeals the corporate alternative minimum tax (AMT) and permits existing minimum tax credits carryovers to offset the regular tax liability for any tax year. Further, the credit is refundable for any tax year beginning after December 31, 2017 and before December 31, 2020 in an amount equal to 50 percent of the excess of the minimum tax credit over regular liability. Any remaining credit will be fully refundable for the year ended December 31, 2021. As of December 31, 2019, the Company had $46,601 of minimum tax credit included in prepaids and other current assets in the accompanying consolidated balance sheet. The Company has approximately $50.6 million in federal net operating loss carryforwards (“NOLs”) available to reduce future taxable income, of which $3.8 million will never expire with the remaining expiring at various dates from 2022 through 2039. Due to the uncertainty as to the Company’s ability to generate sufficient taxable income in the future and utilize the NOLs before they expire and any other deferred tax assets, the Company has recorded a valuation allowance accordingly. The Company’s NOLs are subject to annual limitations as a result of a change in its equity ownership as defined under the Internal Revenue Code Section 382. These limitations, as applicable, could further limit the use of the NOLs. The valuation allowance for deferred tax assets increased by approximately $484,000 in the year ended December 31, 2019. The increase in the valuation allowance was primarily due to taxable loss in the current year. The Company has adopted the provisions of ASU 2016-09 as of the beginning of 2018 which requires recognition through opening retained earnings of any pre-adoption date NOL carryforwards from nonqualified stock options and other employee share-based payments (e.g., restricted shares and share appreciation rights), as well as recognition of all income tax effects from share-based payments arising on or after January 1, 2017 (our adoption date) in income tax expense. In light of the Company’s valuation allowance on its deferred tax assets there was no adjustment required to its retained earnings nor was there any windfall tax benefit to recognize in the Company’s income tax provision. The differences between the United States statutory federal income tax rate and the effective income tax rate in the accompanying consolidated statements of operations are as follows: 2019 2018 Statutory United States federal rate 21.00 % 21.00 % State income taxes net of federal benefit 3.28 % 4.00 % Permanent differences (1.61 )% 2.20 % Other (1.24 )% 0.70 % Foreign taxes (1.09 )% 1.70 % Change in valuation reserves (16.34 )% (28.50) % Effective rate 4.00 % 1.10 % The Company recognizes interest accrued and penalties related to unrecognized tax benefits in tax expense. During the years ended December 31, 2019 and 2018, the Company recognized no interest and penalties. The Company files income tax returns in the U.S. federal jurisdiction and various states. The tax years 2016-2019 generally remain open to examination by major taxing jurisdictions to which the Company is subject.

Defined Contribution Pension Pl

Defined Contribution Pension Plan	12 Months Ended
	Dec. 31, 2019
Retirement Benefits [Abstract]
Defined Contribution Pension Plan	NOTE 12 - DEFINED CONTRIBUTION PENSION PLAN The Company maintains a qualified employee savings plans (the “401(k) Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code and which covers all eligible employees. Employees generally become eligible to participate in the 401(k) Plan two months following the employee’s hire date. Employees may contribute a percentage of their earnings, subject to the limitations of the Internal Revenue Code. Commencing on January 1, 2018, the Company matched 100% of the first 1% of employee contributions, then 50% of additional contributions up to an aggregate maximum match of 3.5%. The total matching contributions for 2019 and 2018 were approximately $123,000 and $136,000, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 13 – COMMITMENTS AND CONTINGENCIES The Company has operating leases predominantly for operating facilities. As of December 31, 2019, the remaining lease terms on our operating leases range from less than one year to approximately four years. Renewal options to extend our leases have not been exercised due to uncertainty. Termination options are not reasonably certain of exercise by the Company. There is no transfer of title or option to purchase the leased assets upon expiration. There are no residual value guarantees or material restrictive covenants. There are no significant finance leases as of December 31, 2019. Rent expense for the year ended December 31, 2019 was approximately $474,000. Future minimum lease payments as of December 31,2019 are as follows: 2020 $ 396,678 2021 304,669 2022 289,997 2023 269,913 2024 21,860 Total lease payments $ 1,283,117 Less imputed interest (60,375 ) Present value of remaining lease payments $ 1,222,742 Current $ 397,097 Non-current $ 825,645 Weighted average remaining lease term (years) 4 Weighted average discount rate 5.4 % Employment Agreements 000. Legal Proceedings On November 26, 2013, DSSTM filed suit against Apple, Inc. (“Apple”) in the United States District Court for the Eastern District of Texas, for patent infringement (the “Apple Litigation”). The complaint alleges infringement by Apple of DSSTM’s patents that relate to systems and methods of using low power wireless peripheral devices. DSSTM is seeking a judgment for infringement, injunctive relief, and compensatory damages from Apple. On October 28, 2014, the case was stayed by the District Court pending a determination of Apple’s motion to transfer the case to the Northern District of California. On November 7, 2014, Apple’s motion to transfer the case to the Northern District of California was granted. On December 30, 2014, Apple filed two Inter Partes Review (“IPR”) petitions with the Patent Trial and Appeal Board (“PTAB”) for review of the patents at issue in the case. The PTAB instituted the IPRs on June 25, 2015. The California District Court then stayed the case pending the outcome of those IPR proceedings. Oral arguments of the IPRs took place on March 15, 2016, and on June 17, 2016, PTAB ruled in favor of Apple on both IPR petitions. DSSTM then filed an appeal with the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) seeking reversal of the PTAB decisions. Oral arguments for the appeal were held on August 9, 2017. On March 23, 2018, the Federal Circuit reversed the PTAB, finding that the PTAB erred when it found the claims of U.S. Patent No. 6,128,290 to be unpatentable. The Federal Circuit affirmed its decision on July 12, 2018, when it denied Apple’s petition for panel rehearing of the Federal Circuit’s Opinion and Judgment issued on March 23, 2018. On July 27, 2018, the District Court judge lifted the Stay resuming the litigation, which had a trial date set for the week of February 24, 2020. On January 14, 2020, the Court in the case DSS Technology Management, Inc. v. Apple, Inc., 4:14-cv-05330-HSG pending in the Northern District of California issued an order that denied DSS’ motion to amend its infringement contentions. In the same Order, the Court granted Apple’s motion to strike DSS’ infringement expert report. DSS filed a motion for leave to file a motion for reconsideration of the Court’s order denying DSS the right to amend its infringement contentions and motion to strike DSS infringement expert report. On February 18, 2020, the Court denied DSS’s motion for leave to file a motion for reconsideration. On February 24, 2020, the Court signed a Final Judgment stipulating that Apple was “entitled to a judgment of non-infringement of U.S. Patent No. 6,128,290 as a matter of law.” DSS intends to appeal the ruling. On February 16, 2015, DSSTM filed suit in the United States District Court, Eastern District of Texas, against defendants Intel Corporation, Dell, Inc., GameStop Corp., Conn’s Inc., Conn Appliances, Inc., NEC Corporation of America, Wal-Mart Stores, Inc., Wal-Mart Stores Texas, LLC, and AT&T, Inc. The complaint alleged patent infringement and sought judgment for infringement of two of DSSTM’s patents, injunctive relief and money damages. On December 9, 2015, Intel filed IPR petitions with PTAB for review of the patents at issue in the case. Intel’s IPRs were instituted by PTAB on June 8, 2016. On June 1, 2017, the PTAB ruled in favor of Intel for all the challenged claims. On July 28, 2017, DSSTM filed a notice of appeal of the PTAB’s decision relating to U.S. Patent 6,784,552 with the Federal Circuit. On January 8, 2019, DSSTM entered into a confidential settlement agreement with Intel Corporation, Dell Inc., GameStop Corp, Conn’s Inc., Conn Appliances, Inc., Wal-Mart Stores, Inc., Wal-Mart Stores Texas, LLC and AT&T Mobility LLC (collectively, the “Defendants”). The Federal Circuit Appeal involving DSSTM and Intel was dismissed on January 16, 2019, and the District Court case against the Defendants was dismissed, as to all the Defendants, on February 5, 2019. On July 16, 2015, DSSTM filed three separate lawsuits in the United States District Court for the Eastern District of Texas alleging infringement of certain of its semiconductor patents. The defendants were SK Hynix et al., Samsung Electronics et al., and Qualcomm Incorporated. Each respective complaint alleges patent infringement and seeks judgment for infringement, injunctive relief and money damages. On November 12, 2015, SK Hynix filed an IPR petition with PTAB for review of the patent at issue in their case. SK Hynix’s IPR was instituted by the PTAB on May 11, 2016. On August 16, 2016, DSSTM and SK Hynix entered into a confidential settlement agreement ending the litigation between them. The pending SK Hynix IPR was then terminated by mutual agreement of the parties on August 31, 2016. On March 18, 2016, Samsung also filed an IPR petition, which was instituted by the PTAB. On September 20, 2017, PTAB ruled in favor of Samsung for all the challenged claims relating to U.S. Patent 6,784,552. DSSTM then appealed this PTAB ruling to the Federal Circuit on November 17, 2017. The Federal Circuit joined this appeal with the Intel appeal effective on December 7, 2017. Qualcomm filed its IPR proceeding on July 1, 2016, which was then later joined with Intel’s IPRs in August 2016 by PTAB. On June 1, 2017, the PTAB ruled in favor of Intel/Qualcomm for all the challenged claims. On July 28, 2017, DSSTM filed a notice of appeal of the PTAB’s decision relating to U.S. Patent 6,784,552 with the Federal Circuit. A confidential patent license agreement was executed by DSSTM on November 14, 2018, covering Samsung and Qualcomm. On December 12, 2018, DSSTM and Samsung entered into a confidential release. On December 27, 2018, DSSTM and Qualcomm entered into a confidential settlement agreement. The DSSTM - Samsung District Court case was dismissed on December 17, 2018. The DSSTM - Samsung Federal Circuit Appeal was dismissed on January 2, 2019. The Federal Circuit Appeal involving DSSTM and Qualcomm was dismissed on January 16, 2019. The DSSTM - Qualcomm District Court case was dismissed on January 16, 2019. As a result, all of DSSTM’s litigation matters originally filed in the District Court for the Eastern District of Texas have been resolved and are now dismissed. On April 13, 2017, the Company filed a patent infringement lawsuit against Seoul Semiconductor Co., Ltd. and Seoul Semiconductor, Inc. (collectively, “Seoul Semiconductor”) in the United States District Court for the Eastern District of Texas, alleging infringement of certain of the Company’s Light-Emitting Diode (“LED”) patents. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 7, 2017, the Company refiled its patent infringement complaint against Seoul Semiconductor in the United States District Court for the Central District of California, Southern Division. On December 3, 2017, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 6,949,771. This IPR was instituted by the PTAB on June 7, 2018. On April 18, 2019, the PTAB issued a written decision determining claims 1-9 of the ‘771 patent unpatentable. The Company did not appeal that determination. On December 21, 2017, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 7,256,486. This IPR was instituted by the PTAB on June 21, 2018. On June 10, 2019, the PTAB issued a written decision determining claims 1-3 of the ‘486 patent unpatentable. On August 12, 2019, the Company filed a Notice of Appeal with the Federal Circuit Court of Appeals challenging the PTAB’s decisions. The Company subsequently filed a motion to vacate and remand the PTAB’s decision in light of intervening precedent under the Appointments Clause. That motion was granted on January 23, 2020. On January 25, 2018, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 7,524,087. This IPR was instituted by the PTAB on July 27, 2018. On July 22, 2019, the PTAB issued a written decision determining claims 1, 6-8, 15, and 17 of the ‘087 patent unpatentable. On September 23, 2019, the Company filed a Notice of Appeal with the Federal Circuit Court of Appeals challenging the PTAB’s decisions. The Company subsequently filed a motion to vacate and remand the PTAB’s decision in light of intervening precedent under the Appointments Clause. That motion was granted on February 3, 2020. These challenged patents are the patents that are the subject matter of the infringement lawsuit, which is pending but stayed pending the outcome of the IPR proceedings. On April 13, 2017, the Company filed a patent infringement lawsuit against Everlight Electronics Co., Ltd. and Everlight Americas, Inc. (collectively, “Everlight”) in the United States District Court for the Eastern District of Texas, alleging infringement of certain of the Company’s LED patents. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 8, 2017, the Company refiled its patent infringement complaint against Everlight in the United States District Court for the Central District of California. On June 8, 2018, Everlight filed IPR petitions challenging the validity of claims under U.S. Patent Nos. 7,256,486 and 7,524,087. On June 12, 2018, Everlight filed an IPR petition challenging the validity of claims under U.S. Patent No. 6,949,771, and on June 15, 2018, filed an IPR petition challenging the validity of claims under U.S. Patent No 7,919,787. These challenged patents are the patents that are the subject matter of the infringement lawsuit. On January 18, 2019, the Company and Everlight entered into a confidential settlement agreement resolving the litigation. On April 13, 2017, the Company filed a patent infringement lawsuit against Cree, Inc. (“Cree”) in the United States District Court for the Eastern District of Texas, alleging infringement of certain of the Company’s LED patents. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 8, 2017, the Company refiled its patent infringement complaint against Cree in the United States District Court for the Central District of California, and thereafter filed a first amended complaint for patent infringement against Cree in that same court on July 14, 2017. The case is currently pending as of the date of this Report. On June 6, 2018, Cree filed an IPR petition challenging the validity of claims under U.S. Patent No. 7,256,486. This IPR was instituted and joined with the Seoul Semiconductor IPR. On June 7, 2018, Cree filed IPR petitions challenging the validity of certain claims U.S. Patent Nos. 7,524,087 and 6,949,771. Both IPRs were denied by the PTAB on November 14, 2018 as time-barred. The challenged patent is the patent that is the subject matter of the infringement lawsuit, which is pending but stayed pending the outcome of the IPR. On August 15, 2017, the Company filed a patent infringement lawsuit against Lite-On, Inc., and Lite-On Technology Corporation (collectively, “Lite-On”) in the United States District Court for the Central District of California, alleging infringement of certain of the Company’s LED patents. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The case is currently pending but is stayed pending the outcome of IPR proceedings filed by other parties. On December 7, 2017, DSS filed a patent infringement lawsuit against Nichia Corporation and Nichia America Corporation in the United States District Court for the Central District of California, alleging infringement of certain of DSS’s LED patents. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The case is currently pending as of the date of this Report. On May 10, 2018, Nichia filed an IPR petition challenging the validity of claims under U.S. Patent No. 7,919,787. On May 11, 2018, Nichia filed an IPR petition challenging the validity of claims under U.S. Patent No. 7,652,297. On May 25, 2018, Nichia filed an IPR petition challenging the validity of claims under U.S. Patent No. 7,524,087. On May 29, 2018, Nichia filed an IPR petition challenging the validity of claims under U.S. Patent No. 6,949,771. On May 30, 2018, Nichia filed an IPR petition challenging the validity of claims under U.S. Patent No. 7,256,486. The 6,949,771 IPR was denied institution, but the remaining IPRs were instituted by the PTAB. On December 10, 2018, Nichia refiled IPRs relating to 6,949,771, which was denied by the PTAB on April 15, 2019. These challenged patents are the patents that are the subject matter of the infringement lawsuit, which is pending but stayed pending the outcome of the IPR proceedings. On September 17, 2019, the PTAB issued a written decision determining claims 1-14 of the ‘787 patent unpatentable. The Company did not appeal that determination. On October 30, 2019, the PTAB issued a written decision determining claims 1-17 of the ‘297 patent unpatentable. The Company did not appeal that determination. On November 19, 2019, the PTAB issued a written decision determining claims 1-5 of the ‘486 patent unpatentable. The Company has appealed that determination to the U.S. Court of Appeals for the Federal Circuit. On September 18, 2019, DSS filed a patent infringement lawsuit against Seoul Semiconductor Co., Ltd. and Seoul Semiconductor Inc. in the United States District Court for the Central District of California alleging infringement of U.S. Patent No. 7,315,119. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The Court has conducted an initial scheduling conference and has set a procedural schedule for the case. On September 19, 2019, DSS filed a patent infringement lawsuit against Cree, Inc. in the United States District Court for the Central District of California alleging infringement of U.S. Patent No. 6,784,460. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On February 11, 2020, Dree filed an IPR petition challenging the validity of the patent claims. The Court has conducted an initial scheduling conference and has set a procedural schedule for the case. On September 20, 2019, DSS filed a patent infringement lawsuit against Nichia Corp. and Nichia America Corp. in the United States District Court for the Central District of California alleging infringement of U.S. Patent No. 6,879,040. The Company is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The Court has conducted an initial scheduling conference and has set a procedural schedule for the case. In April 2019 DSS commenced an action in New York State Supreme Court, Monroe County against Jeffrey Ronaldi, our former Chief Executive Officer. This New York action seeks a declaratory judgment that, contrary to informal claims made by him, Mr. Ronaldi’s employment agreement with us expired by its terms and that he is not entitled to any cash bonuses or other unpaid amounts. The lawsuit also seeks an injunction against Mr. Ronaldi from interfering with any of DSS’ IP litigation. The defendant has been granted an extension to respond pending settlement negotiations. Mr. Ronaldi subsequently commenced an action against us in the Superior Court of California, County of San Diego, in November 2019, in which he alleges that we terminated his employment in April 2019 in order to avoid paying him certain employment-related amounts. Mr. Ronaldi contends that he is owed a $100,000 performance bonus for 2017 under this employment agreement with us as well as $91,000 in documented and unreimbursed expenses, and that DSS purported to terminate him for cause under the terms of his employment agreement in order to avoid paying such amounts. Mr. Ronaldi also contends that he is entitled to receive additional amounts, either under the terms of the employment agreement, or under theories of implied-in-fact contract or promissory estoppel, including, but not limited to, (i) additional performance bonuses of up to 15% of net litigation proceeds received by us from pending patent infringement litigations, of net licensing proceeds received by us other than from our internally developed IP, or of the net sales proceeds received by us in connection with the sale of any of our patent assets, (ii) earned but unpaid base salary, (iii) an equity grant of shares of our common stock, and (iv) payments for unused personal time and sick days. He seeks actual, compensatory, restitutionary and/or incidental damages in an amount to be determined at trial; prejudgment interest in an amount to be determined at trial; attorneys’ fees and costs; other costs of the suit; and such other and further relief as the court deems proper. We have made a motion to have the case dismissed and consolidated with the Monroe Co., New York, litigation. A hearing has been set for April 24, 2020, for the court to consider that request. Additionally, on March 2, 2020 DSS and DSSTM filed a second litigation action against Jeffrey Ronaldi in the State of New York, Supreme Court, County of Monroe alleging acts of self-dealing and conflicts of interest while he served as CEO of both DSS and DSS TM. That litigation is in the process of being served upon the defendant. On November 20, 2019, DSS Technology Management was sued in the United States District Court, Northern District of California, by Intel Corporation (“Intel”) and Apple Inc. (“Apple”). The other defendants in the litigation are Fortress Investment Group LLC, Fortress Credit Co. LLC, Uniloc 2017 LLC, Uniloc USA, INC., Uniloc Luxembourg S.A.R.L., VLSI Technology LLC, INVT SPE LLC, Inventergy Global, INC., IXI IP, LLC, and Seven Networks, LLC. The complaint includes allegations regarding a February 13, 2014 Investment Agreement between DSS Technology Management and Fortress Credit Co. LLC as well as two subsequent agreements. The complaint also contains allegations regarding DSS Technology Management’s lawsuit against Intel that was filed in February 2015 in the United States District Court, Eastern District of Texas (referred to below). In the complaint, Intel and Apple allege violations of Section 1 of the Sherman Act and unfair competition under Cal. Bus. & Prof. Code § 17200 against DSS Technology Management. Additional claims are alleged against other defendants. Intel and Apple seek relief from the court including that defendants’ conduct be declared a violation of Section 1 of the Sherman Act, Section 7 of the Clayton Act, and Cal. Bus. & Prof. Code § 17200, et seq.; that Intel and Apple recover damages against defendants in an amount to be determined and multiplied to the extent provided by law, including under Section 4 of the Clayton Act; that all contracts or agreements defendants entered into in violation of the Sherman Act, Clayton Act, or Cal. Bus. & Prof. Code § 17200, et seq. be declared void and the patents covered by those transfer agreements be transferred back to the transferors; that all patents transferred to defendants in violation of the Sherman Act, Clayton Act, or Cal. Bus. & Prof. Code § 17200, et seq. be declared unenforceable; and that Intel and Apple recover their costs and expenses associated with this case, together with interest. On December 13, 2019, the court granted the parties’ stipulation to extend the deadline for DSS Technology Management and other defendants to respond to the complaint to February 4, 2020. A hearing on any motions filed in response to the complaint is set for April 23, 2020. In addition to the foregoing, we may become subject to other legal proceedings that arise in the ordinary course of business and have not been finally adjudicated. Adverse decisions in any of the foregoing may have a material adverse effect on our results of operations, cash flows or our financial condition. The Company accrues for potential litigation losses when a loss is probable and estimable. Contingent Litigation Payments Contingent Payments

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	NOTE 14 - SUPPLEMENTAL CASH FLOW INFORMATION Supplemental cash flow information for the years ended December 31: 2019 2018 Cash paid for interest $ 157,000 $ 133,000 Non-cash investing and financing activities: Impact of adoption of lease accounting standards $ 1,568,000 $ - Gain from change in fair value of interest rate swap derivatives $ 7,000 $ 16,000 Common stock issued upon conversion of convertible note $ 500,000 $ - Equity issued to purchase intangible assets $ 145,000 $ - Elimination of contingent liabilities through agreement $ - $ 459,000 Purchase of intangible assets to be paid in installments $ - $ 304,000 Purchase of intangible assets with term note inclusive of tax $ - $ 119,065

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Segment Information	NOTE 15 - SEGMENT INFORMATION The Company’s businesses are organized, managed and internally reported as four operating segments. Two of these operating segments, Packaging and Printing, and Plastics are engaged in the printing and production of paper, cardboard and plastic documents with a wide range of features, including the Company’s patented technologies and trade secrets designed for the protection of documents against unauthorized duplication and altering. A third operating segment, Digital, is comprised of DSS Digital Group, and DSS International, and is As reported herein, DSS is in the process of establishing several new business lines, and we anticipate each of these new business division to be future operating segments. For instance, Direct Marketing is a newly added operating segment in December 2019 and focuses on e.g Approximate information concerning the Company’s operations by reportable segment for the years ended December 31, 2019 and 2018 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Year Ended December 31, 2019 Packaging and Printing Plastics Digital Technology Corporate Total Revenue $ 13,230,000 $ 3,860,000 $ 2,147,000 $ - $ 172,000 $ 19,409,000 Depreciation and amortization 904,000 253,000 33,000 82,000 132,000 1,404,000 Interest expense 96,000 32,000 7,000 - 22,000 157,000 Amortized Debt Discount 2,000 - - - - 2,000 Stock based compensation 17,000 - 81,000 - 324,000 422,000 Income tax benefit - - - - (125,000 ) (125,000 ) Net Income (loss) 311,000 (294,000 ) (579,000 ) (475,000 ) (1,852,000 ) (2,889,000 ) Capital Expenditures 819,000 42,000 24,000 - 104,000 989,0000 Identifiable assets 10,425,000 3,934,000 924,000 58,000 4,804,000 20,145,000 Year Ended December 31, 2018 Packaging and Printing Plastics Digital Technology Corporate Total Revenue $ 12,957,000 $ 3,983,000 $ 1,543,000 $ 32,000 $ - $ 18,515,000 Depreciation and amortization 775,000 159,000 8,000 338,000 2,000 1,282,000 Interest Expense (89,000 ) (24,000 ) (13,000 ) (19,000 ) (145,000 ) Amortized Debt Discount (2,000 ) - (22,000 ) (22,000 ) (46,000 ) Stock based compensation 6,000 - 99,000 - 27,000 132,000 Income tax expense - - - - 17,000 17,000 Net Income (loss) 785,000 28,000 (1,267,000 ) 3,028,000 (1,109,000 ) 1,465,000 Capital Expenditures 643,000 305,000 54,000 - 1,000 1,003,000 Identifiable assets 9,643,000 3,492,000 955,000 130,000 1,060,000 15,280,000 International revenue, which consists of sales to customers with operations in Canada, Western Europe, Latin America, Africa, the Middle East and Asia comprised 2.0% of total revenue for 2019 (3.4% - 2018). Revenue is allocated to individual countries by customer based on where the product is shipped. The Company had no long-lived assets in any country other than the United States for any period presented. The following tables disaggregate our business segment revenues by major source: Printed Products Revenue Information: Twelve months ended December 31, 2019 Packaging Printing and Fabrication $ 12,307,000 Commercial and Security Printing 1,159,000 Technology Integrated Plastic Cards and Badges 1,262,000 Plastic Cards, Badges and Accessories 2,361,000 Total Printed Products $ 17,089,000 Twelve months ended December 31, 2018 Packaging Printing and Fabrication $ 11,741,000 Commercial and Security Printing 1,241,000 Technology Integrated Plastic Cards and Badges 1,354,000 Plastic Cards, Badges and Accessories 2,604,000 Total Printed Products $ 16,940,000 Technology Sales, Services and Licensing Revenue Information: Twelve months ended December 31, 2019 Information Technology Sales and Services $ 189,000 Digital Authentication Products and Services 1,414,000 Royalties from Licensees 545,000 Total Technology Sales, Services and Licensing $ 2,148,000 Twelve months ended December 31, 2018 Information Technology Sales and Services $ 345,000 Digital Authentication Products and Services 772,000 Royalties from Licensees 458,000 Total Technology Sales, Services and Licensing $ 1,575,000

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	NOTE 16 – SUBSEQUENT EVENTS On March 12, 2020, the Company entered into a binding term sheet (the “Term Sheet”) with DSS BioHealth Security, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“DBHS”), Global BioMedical Pte Ltd, a Singapore corporation (“GBM”), and Impact BioMedical Inc., a Nevada corporation and wholly owned subsidiary of GBM (“Impact”). Pursuant to the Term Sheet, the Company will acquire Impact, a company engaged in the development and marketing of biohealth security technologies, in a proposed share exchange transaction with a purchase price capped at $50 million, subject to completion of due diligence and an independent valuation. In consideration of 100% of Impact, the Company will issue GBM (i) up to 14,500,000 shares of its common stock, par value $0.02 (the “Common Stock”), at a price of $0.216 per share (valued at $3,132,00), and (ii) perpetual convertible preferred stock (“Convertible Preferred Stock”) for the remaining balance of the purchase price, as adjusted by the independent valuation and subject to a 19.9% blocker based on the total issued outstanding shares of Common Stock held or to be held by GBM. Pursuant to the Term Sheet, in consideration for the Convertible Preferred Stock, the Company will have certain rights, including appointing members of the Board of Directors of Impact, as set forth in the Term Sheet. GBM is a 100% owned subsidiary of Singapore eDevelopment Limited whose Chief Executive Office and largest shareholder is Mr. Heng Fai Ambrose Chan, the Chairman of the Board and largest shareholder of the Company. As such, the above transactions constitute related party transactions which have been duly approved by the Company’s Board of Directors and Audit Committee. On March 3, 2020, the Company entered into a binding term sheet (the “Term Sheet”) with LiquidValue Asset Management Pte Ltd (“LVAM”), AMRE Asset Management Inc. (“AAMI”) and American Medical REIT Inc. (“AMRE”), regarding a share subscription and loan arrangement. The Term Sheet sets out the terms of a proposed joint venture to establish a medical real estate investment trust in the United States. Pursuant to the Term Sheet, the Company will subscribe for 5,250 ordinary shares of AAMI at a purchase price of $0.01 per share for total consideration of $52.50. Concurrently, AAMI will issue 2,500 shares to LVAM, and 1,250 shares to AMRE Tennessee, LLC, AMRE’s executive management’s holding company (collectively, the “Subscription Shares”). As a result, the Company will hold 52.5% of the outstanding shares of AAMI, with LVAM and AMRE Tennessee, LLC, holding 35% and 12.5% of the remaining outstanding shares of AAMI, respectively. Further, pursuant to and in connection with the Term Sheet, on March 3, 2020, the Company entered into a Promissory Note with AMRE, pursuant to which AMRE will issue the Company a promissory note for the principal amount of $800,000.00 (the “Note”). The Note matures on March 3, 2022 and accrues interest at the rate of 8.0% per annum, and shall be payable in accordance with the terms set forth in the Note. As further incentive to enter into the Note, AMRE issued the Company warrants to purchase 160,000 shares of AMRE common stock (the “Warrants”). The Warrants have an exercise price of $5.00 per share, subject to adjustment as set forth in the Warrant, and expire on March 3, 2024. On February 25, 2020, the Company, closed its previously announced underwritten public offering of 25,555,556 shares of its common stock. The Offering included 22,222,223 shares of the Company’s common stock, and 3,333,333 additional shares from the exercise of the underwriter’s purchase option to cover over-allotments at the public offering price of $0.18 per share. The net offering proceeds (inclusive of the over-allotment exercise) to the Company approximated $4.0 million. Mr. Heng Fai Ambrose Chan, the Chairman of the Board, purchased 11,111,112 shares of Common Stock in the Offering, for an aggregate purchase price of $2,000,000. In January 2020, the Company began foreclosure proceedings on both of its Note receivables with RBC identified in Note 4. These proceedings were finalized in February 2020. The Company chose to forego the optional conversion of the outstanding principal and interest into 75% ownership and 100% ownership, respectively, as was allowed in the terms of both agreements. In lieu of common stock, the Company took ownership of certain assets of RBC. Management has concluded that the fair value of these assets equal or exceeds the amounts outstanding under the obligations. Impact of COVID-19 Outbreak On January 30, 2020, the World Health Organization declared the coronavirus outbreak a “Public Health Emergency of International Concern” and on March 10, 2020, declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the coronavirus include restrictions on travel, and quarantines in certain areas, and forced closures for certain types of public places and businesses. The coronavirus and actions taken to mitigate it have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. While the closures and limitations on movement, domestically and internationally, are expected to be temporary, if the outbreak continues on its current trajectory the duration of the supply chain disruption could reduce the availability, or result in delays, of materials or supplies to and from the Company, which in turn could materially interrupt the Company’s business operations. Given the speed and frequency of the continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the impact to its consolidated results of operations. The Company’s manufacturing facilities in both California and New York support businesses have been deemed essential by their respective state governments and remain operational. We have taken every precaution possible to ensure the safety of our employees. Additionally, it is reasonably possible that estimates made in the financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including losses on inventory; impairment losses related to goodwill and other long-lived assets and current obligations. Subsequent to December 31, 2019, the Company has invested approximately $460,000 for less than 10% ownership of an entity over which one of the Company’s directors serves as CEO.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates
Reclassifications	Reclassifications
Cash Equivalents	Cash Equivalents -
Accounts Receivable	Accounts Receivable
Inventory	Inventory
Property, Plant and Equipment	Property, Plant and Equipment
Investment	Investment
Goodwill	Goodwill -
Other Intangible Assets and Patent Application Costs	Other Intangible Assets and Patent Application Costs
Impairment of Long-lived Assets	Impairment of Long-Lived Assets
Fair Value of Financial Instruments	Fair Value of Financial Instruments ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts reported in the balance sheet of cash and cash equivalents, accounts receivable, prepaids, accounts payable and accrued expenses approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair value of notes receivable approximates their carrying value as the stated or discounted rates of the notes do not reflect recent market conditions. The fair value of revolving credit lines notes payable and long-term debt approximates their carrying value as the stated or discounted rates of the debt reflect recent market conditions. Derivative instruments, as discussed below, are recorded as assets and liabilities at estimated fair value based on available market information. The fair value of investments carried at cost less impairment; however, the fair value is not considered readily determinable based on the lack of liquidity for the shares owned.
Derivative Instruments	Derivative Instruments
Share-based Payments	Share-Based Payments
Revenue Recognition	Revenue Recognition The Company sells printed products including packaging printing and fabrication, commercial and security printing and plastic cards and badges, including cards and badges integrated with technology such as RFID and smart chips. The Company also provides information technology services and digital authentication products and services to its customers. The Company recognizes its products and services revenue based on when the title passes to the customer or when the service is completed and accepted by the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for shipped product or service provided. Sales and other taxes billed and collected from customers are excluded from revenue. Customers, including distributors, do not have a general right of return. The Company also derives revenue from royalties from third parties which are typically based on licensees’ net sales of products that utilize the Company’s technology, or on a per item usage of the technology on the customers’ printed products. The Company recognizes license revenue at the time it is reported by the licensee. From time to time, the Company generates license revenues through litigation settlements. For these, the Company recognizes revenue upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met. As of December 31, 2019, the Company had no unsatisfied performance obligations for contracts with an original expected duration of greater than one year. Pursuant to Topic 606, the Company has applied the practical expedient with respect to disclosure of the deferral and future expected timing of revenue recognition for transaction price allocated to remaining performance obligations. The Company elected the practical expedient allowing it to not recognize as a contract asset the commission paid to its salesforce on the sale of its products as an incremental cost of obtaining a contract with a customer but rather recognize such commission as expense when incurred as the amortization period of the asset that the Company would have otherwise recognized is one year or less. Sales Commissions Sales commissions are expensed as incurred for contracts with an expected duration of one year or less. There were no sales commissions capitalized as of December 31, 2019. Shipping and Handling Costs Costs incurred by the Company related to shipping and handling are included in cost of products sold. Amounts charged to customers pertaining to these costs are reflected as revenue.
Costs of Revenue	Costs of revenue -
Contingent Legal Expenses	Contingent Legal Expenses -
Advertising Costs	Advertising Costs .
Research and Development	Research and Development the Company’s AuthentiGuard product line
Income Taxes	Income Taxes
Earnings Per Common Share	Earnings Per Common Share As of December 31, 2019, and 2018, there were 1,798,221 and 2,212,773, respectively, of common stock share equivalents potentially issuable under options, warrants, and restricted stock agreements that could potentially dilute basic earnings per share in the future. For the twelve-months ended December 31, 2019, equivalents were excluded from the calculation of diluted earnings per share since their inclusion would have been anti-dilutive. For the twelve-months ended December 31, 2018, based on the average market price of the Company’s common stock during that period of $1.27, 206,429 common stock equivalents were added to the basic shares outstanding to calculate dilutive earnings per share.
Comprehensive Income (loss)	Comprehensive Income (Loss)
Concentration of Credit Risk	Concentration of Credit Risk During 2019, two customers accounted for 45% of our consolidated revenue. As of December 31, 2019, these two customers accounted for 49% of our consolidated trade accounts receivable balance. As of December 31, 2018, these two customers accounted for 44% of our consolidated revenue and 38% of our consolidated trade accounts receivable balance.
Continuing Operations and Going Concern	Continuing Operations and Going Concern – The expected use of cash for operations in 2020 will be primarily for funding operating losses, working capital, legal expenses associated with intellectual property related litigation, and the costs associated with the global roll-out of the Company’s AuthentiGuard product line. The Company will also use these funds to make capital improvements at its two manufacturing facilities to increase production capacity and create efficiencies, as well as to diversify its revenue streams and take advantage of profit opportunities. The Company’s management intends to take actions necessary to continue as a going concern. Management’s plans concerning these matters includes, among other things, continued growth among our operating segments including international expansion of our AuthentiGuard product, and tightly controlling operating costs and reducing spending growth rates wherever possible to return to profitability. We believe that our $1.1 million in aggregate cash and equivalents as of December 31, 2019 as well as the $4.0 million raised on February 25, 2020 will allow us to fund our four operating segments current and planned operations through March 2021. Based on this, we have concluded that substantial doubt of our ability to continue as a going concern has been alleviated.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02 and its related amendments which introduced Leases (Topic 842, or “ASC 842”), a new comprehensive lease accounting model that supersedes the current lease guidance under Leases (Topic 840). The new accounting standard requires lessees to recognize right-of-use (“ROU”) assets and corresponding lease liabilities for all leases with lease terms of greater than 12 months. It also changes the definition of a lease and expands the disclosure requirements of lease arrangements. In July 2018, the FASB added a transition option for implementation that allows companies to continue to use the legacy guidance in ASC 840, Leases, including its disclosure requirements, in the comparative periods presented in the year of adoption. The Company adopted the guidance effective January 1, 2019. The Company elected the transition package of three practical expedients permitted under the transition guidance and elected the optional transition method that allows for a cumulative-effect adjustment in the period of adoption, without a restatement of prior periods. Further, the Company elected a short-term lease exception policy, permitting the Company to not apply the recognition requirements of this standard to short-term leases (i.e. leases with terms of 12 months or less). As a result of the adoption, the Company adjusted its beginning balance as of January 1, 2019 by recording operating lease ROU asset and liabilities through a cumulative-effect adjustment. The adoption impacted the accompanying consolidated balance sheet, but did not have an impact on the consolidated statements of operations and comprehensive income (loss). At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company calculates the associated lease liability and corresponding ROU assets upon lease commencement using a discount rate based on a credit adjusted secured borrowing rate commensurate with the term of the lease. The Company records lease liabilities within current or noncurrent liabilities based upon the length of time associated with the lease payments. The operating lease ROU assets includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any, and are recorded as noncurrent assets. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with an initial term of 12 months or less are not recorded on the accompanying consolidated balance sheet. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The impact of the adoption of ASC 842 on the accompanying consolidated balance sheet as of January 1, 2019 was a right-of-use asset and a lease liability of approximately $1,443,800.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments-Credit Losses (Topic 326)”, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. This guidance is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently assessing the impact that adopting this new accounting standard will have on our consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment”, which eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. The annual assessment of goodwill impairment will be determined by using the difference between the carrying amount and the fair value of the reporting unit. The standards update is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently assessing the impact that adopting this new accounting standard will have on its Consolidated Financial Statements and plans to adopt ASU 2017-04 in the first quarter of 2020.

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2019
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consisted of the following at December 31: 2019 2018 Finished Goods $ 1,097,616 $ 1,144,695 Work in Process 246,159 339,091 Raw Materials 363,915 79,807 $ 1,707,690 $ 1,563,593

Property Plant and Equipment (T

Property Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following at December 31: Estimated 2019 2018 Machinery and equipment 5-10 years 8,567,911 7,723,763 Building and improvements 39 years 1,961,544 1,923,027 Land 185,000 185,000 Leasehold improvements 3-10 years 776,674 760,286 Furniture and fixtures 7 years 109,862 94,364 Software and websites 3 years 298,797 187,511 Total Cost 11,899,788 10,873,951 Less accumulated depreciation 6,839,090 5,859,457 Property, plant and equipment, net 5,060,698 5,014,494

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets are comprised of the following: 2019 2018 Useful Gross Accumulated Net Gross Accumulated Net Acquired intangibles customer lists, licenses and non-compete agreements 2-10 years 1,788,699 1,202,832 585,867 1,284,065 823,884 460,181 Acquired intangibles patents and patent rights 500,000 500,000 - 500,000 500,000 - Patent application costs Varied (1) 1,178,176 829,278 348,898 1,168,155 746,925 421,230 3,466,875 2,532,110 934,765 2,952,220 2,070,809 881,411 (1) Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2019, the weighted average remaining useful life of these assets in service was approximately 6.9 years.
Schedule of Estimated Future Amortization of Intangible Assets	Expected amortization for each of the five succeeding fiscal years is as follows: Year Amount 2020 383,276 2021 273,626 2022 127,408 2023 39,378 2024 19,112

Short Term and Long-Term Debt (

Short Term and Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Schedule of Notes Payable and Long-Term Debt	A summary of scheduled principal payments of long-term debt, not including revolving lines of credit and other debt which can be settled with non-monetary assets, subsequent to December 31, 2019 are as follows: Year Amount 2020 $ 440,699 2021 307,324 2022 322,160 2023 322,926 2024 185,218 Thereafter $ 1,186,387

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Schedule of Warrant Activity	The following is a summary with respect to warrants outstanding and exercisable at December 31, 2019 and 2018 and activity during the years then ended: 2019 2018 Number of Warrants Weighted Average Exercise Price Number of Warrants Weighted Average Exercise Price Outstanding at January 1, 1,430,116 $ 4.00 2,645,090 $ 10.98 Granted - - - - Lapsed/terminated (209,812 ) 20.78 (1,214,974 ) 19.20 Outstanding at December 31, 1,220,304 $ 1.12 1,430,116 $ 4.00 Exercisable at December 31, 1,220,304 $ 1.12 1,430,116 $ 4.00 Weighted average of months remaining 20.7 27.9
Summary of Stock Option Activity Under Stock Option and Incentive Plans	The following is a summary with respect to options outstanding at December 31, 2019 and 2018 and activity during the years then ended: 2019 2018 Number of Options Weighted Average Exercise Price Weighted Average life Remaining (Years) Number of Options Weighted Average Exercise Price Weighted Average life Remaining (Years) Outstanding at January 1, 782,655 $ 6.66 482,667 $ 10.72 Granted - - 405,000 1.38 Lapsed/terminated (204,738 ) 7.7 (105,012 ) 4.96 Outstanding at December 31, 577,917 $ 5.01 3.2 782,655 $ 6.66 3.2 Exercisable at December 31, 408,750 $ 6.50 3.5 490,988 $ 8.30 2.8 Expected to vest at December 31, 169,167 $ 1.43 3.4 291,667 $ 1.41 4.5 Aggregate intrinsic value of outstanding options at December 31, $ - $ - Aggregate intrinsic value of exercisable options at December 31, $ - $ - Aggregate intrinsic value of options expected to vest at December 31, $ - $ -
Schedule of Assumptions Used to Compute the Share-based Compensation Expense for Stock Options and Warrants	The following table shows our weighted average assumptions used to compute the share-based compensation expense for stock options and warrants granted during the year ended December 31, 2018. There were no options or warrants granted for compensation during the year ended December 31, 2019. Volatility 98.20 % Expected option term 3.6 years Risk-free interest rate 2.7 % Expected forfeiture rate 0.0 % Expected dividend yield 0.0 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of Income Tax Provision	The provision (benefit) for income taxes consists of the following: 2019 2018 Currently payable: Federal $ - $ - State (68 ) 6,920 Total currently payable (68 ) 6,920 Deferred: Federal (367,473 ) 458,446 State (124,975 ) 67,451 Foreign (116,863 ) (92,690.00 ) Total deferred (609,311 ) 433,207 Less: increase in allowance 476,972 (423,534 ) Net deferred (125,419 ) 9,673 Total income tax provision $ (125,487 ) $ 16,593
Schedule of Deferred Tax Assets and Liabilities	Individual components of deferred taxes are as follows: Deferred tax assets: 2019 2018 Net operating loss carry forwards $ 11,188,858 $ 10,135,005 Equity issued for services 169,445 152,240 Goodwill and other intangibles 675,885 788,288 Investment in pass-through entity 11,621 11,499 Deferred revenue 181,519 472,466 Operating Lease Liability 284,193 - Other 376,462 470,780 Gross deferred tax assets 12,887,983 12,030,278 Deferred tax liabilities: Goodwill and other intangibles 29,046 33,333 Depreciation and amortization - 31,512 Right -of-use asset 284,193 - Gross deferred tax liabilities 313,239 64,845 Less: valuation allowance (12,618,311 ) (12,134,419 ) Net deferred tax liabilities $ (43,567 ) $ (168,986 )
Schedule of Effective Income Tax Rate Reconciliation	The differences between the United States statutory federal income tax rate and the effective income tax rate in the accompanying consolidated statements of operations are as follows: 2019 2018 Statutory United States federal rate 21.00 % 21.00 % State income taxes net of federal benefit 3.28 % 4.00 % Permanent differences (1.61 )% 2.20 % Other (1.24 )% 0.70 % Foreign taxes (1.09 )% 1.70 % Change in valuation reserves (16.34 )% (28.50) % Effective rate 4.00 % 1.10 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Payments Under Operating Leases	Future minimum lease payments as of December 31,2019 are as follows: 2020 $ 396,678 2021 304,669 2022 289,997 2023 269,913 2024 21,860 Total lease payments $ 1,283,117 Less imputed interest (60,375 ) Present value of remaining lease payments $ 1,222,742 Current $ 397,097 Non-current $ 825,645 Weighted average remaining lease term (years) 4 Weighted average discount rate 5.4 %

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Information [Abstract]
Schedule of Supplemental Cash Flow Information	Supplemental cash flow information for the years ended December 31: 2019 2018 Cash paid for interest $ 157,000 $ 133,000 Non-cash investing and financing activities: Impact of adoption of lease accounting standards $ 1,568,000 $ - Gain from change in fair value of interest rate swap derivatives $ 7,000 $ 16,000 Common stock issued upon conversion of convertible note $ 500,000 $ - Equity issued to purchase intangible assets $ 145,000 $ - Elimination of contingent liabilities through agreement $ - $ 459,000 Purchase of intangible assets to be paid in installments $ - $ 304,000 Purchase of intangible assets with term note inclusive of tax $ - $ 119,065

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Schedule of Operations by Reportable Segment	Approximate information concerning the Company’s operations by reportable segment for the years ended December 31, 2019 and 2018 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Year Ended December 31, 2019 Packaging and Printing Plastics Digital Technology Corporate Total Revenue $ 13,230,000 $ 3,860,000 $ 2,147,000 $ - $ 172,000 $ 19,409,000 Depreciation and amortization 904,000 253,000 33,000 82,000 132,000 1,404,000 Interest expense 96,000 32,000 7,000 - 22,000 157,000 Amortized Debt Discount 2,000 - - - - 2,000 Stock based compensation 17,000 - 81,000 - 324,000 422,000 Income tax benefit - - - - (125,000 ) (125,000 ) Net Income (loss) 311,000 (294,000 ) (579,000 ) (475,000 ) (1,852,000 ) (2,889,000 ) Capital Expenditures 819,000 42,000 24,000 - 104,000 989,0000 Identifiable assets 10,425,000 3,934,000 924,000 58,000 4,804,000 20,145,000 Year Ended December 31, 2018 Packaging and Printing Plastics Digital Technology Corporate Total Revenue $ 12,957,000 $ 3,983,000 $ 1,543,000 $ 32,000 $ - $ 18,515,000 Depreciation and amortization 775,000 159,000 8,000 338,000 2,000 1,282,000 Interest Expense (89,000 ) (24,000 ) (13,000 ) (19,000 ) (145,000 ) Amortized Debt Discount (2,000 ) - (22,000 ) (22,000 ) (46,000 ) Stock based compensation 6,000 - 99,000 - 27,000 132,000 Income tax expense - - - - 17,000 17,000 Net Income (loss) 785,000 28,000 (1,267,000 ) 3,028,000 (1,109,000 ) 1,465,000 Capital Expenditures 643,000 305,000 54,000 - 1,000 1,003,000 Identifiable assets 9,643,000 3,492,000 955,000 130,000 1,060,000 15,280,000
Schedule of Disaggregation of Revenue	The following tables disaggregate our business segment revenues by major source: Printed Products Revenue Information: Twelve months ended December 31, 2019 Packaging Printing and Fabrication $ 12,307,000 Commercial and Security Printing 1,159,000 Technology Integrated Plastic Cards and Badges 1,262,000 Plastic Cards, Badges and Accessories 2,361,000 Total Printed Products $ 17,089,000 Twelve months ended December 31, 2018 Packaging Printing and Fabrication $ 11,741,000 Commercial and Security Printing 1,241,000 Technology Integrated Plastic Cards and Badges 1,354,000 Plastic Cards, Badges and Accessories 2,604,000 Total Printed Products $ 16,940,000 Technology Sales, Services and Licensing Revenue Information: Twelve months ended December 31, 2019 Information Technology Sales and Services $ 189,000 Digital Authentication Products and Services 1,414,000 Royalties from Licensees 545,000 Total Technology Sales, Services and Licensing $ 2,148,000 Twelve months ended December 31, 2018 Information Technology Sales and Services $ 345,000 Digital Authentication Products and Services 772,000 Royalties from Licensees 458,000 Total Technology Sales, Services and Licensing $ 1,575,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Feb. 25, 2020	Jul. 18, 2019	Jun. 05, 2019	Dec. 31, 2019	Dec. 31, 2018	Jan. 02, 2019
Significant Accounting Policies [Line Items]
Reserve for doubtful accounts				$ 41,000	$ 50,000
Inventory reserve
Depreciation expense				943,000	795,000
Goodwill				2,453,597	2,453,597
Settlement of Interest rate swap				22,483
Advertising costs				81,000	67,000
Research and development				12,000	$ 146,000
Refund on development costs				$ 33,000
Antidilutive securities basic shares outstanding to calculate dilutive earnings				1,798,221	2,212,773
Average market price of common stock					$ 1.27
Dilutive common shares used to eps basic					206,429
Cash				$ 1,096,248	$ 2,447,985
Working capital				$ 3,200,000
Common stock shares exercised		519,186
Proceeds from net offering		$ 5,000,000
Right of use asset and lease liability						$ 1,443,800
Subsequent Event [Member]
Significant Accounting Policies [Line Items]
Issuance of public offering shares of common stock	25,555,556
Proceeds from net offering	$ 4,000,000
Customer One [Member] | Sales Revenue, Goods, Net [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage				45.00%	44.00%
Customer One [Member] | Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage				49.00%	38.00%
Customer Two [Member] | Sales Revenue, Goods, Net [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage				45.00%	44.00%
Customer Two [Member] | Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage				49.00%	38.00%
Plastic Printing Professionals [Member]
Significant Accounting Policies [Line Items]
Goodwill				$ 685,000	$ 685,000
Premier Packaging Corp [Member]
Significant Accounting Policies [Line Items]
Goodwill				$ 1,798,600	$ 1,798,600
Aegis Capital Corp [Member] | Underwriting Agreement Member]
Significant Accounting Policies [Line Items]
Issuance of public offering shares of common stock			11,200,000
Option to purchase shares of common stock			2,000,000
Aegis Capital Corp [Member] | Underwriting Agreement Member] | Subsequent Event [Member]
Significant Accounting Policies [Line Items]
Issuance of public offering shares of common stock	25,555,556
Aegis Capital Corp [Member] | Underwriting Agreement Member] | Subsequent Event [Member] | Over-Allotment [Member]
Significant Accounting Policies [Line Items]
Issuance of public offering shares of common stock	3,333,333
Proceeds from net offering	$ 4,000,000
Aegis Capital Corp [Member] | Underwriting Agreement Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Option to purchase shares of common stock			1,680,000

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Finished Goods	$ 1,097,616	$ 1,144,695
Work in Process	246,159	339,091
Raw Materials	363,915	79,807
Inventory	$ 1,707,690	$ 1,563,593

Notes Receivable (Details Narra

Notes Receivable (Details Narrative) - USD ($)	Oct. 10, 2019	Nov. 11, 2019	Dec. 31, 2019
Outstanding principle and interest			$ 82,451
Two Separate Convertible Preferred Promissory Notes [Member]
Convertible debt		$ 200,000
Debt instrument interest rate percentage		6.00%
Debt maturity date		Nov. 11, 2019
Newly issued common stock shares percentage		75.00%
Century TBD Holdings, LLC [Member]
Convertible debt	$ 500,000
Debt conversion percentage	19.80%
Debt instrument interest rate percentage	6.00%
Debt maturity date	Oct. 9, 2021
Outstanding principle and interest	$ 506,756
RBC Life Sciences, Inc [Member] | Second Note [Member]
Convertible debt			$ 800,000
Debt instrument interest rate percentage			10.00%
Debt maturity date			Nov. 11, 2024
Outstanding principle and interest			$ 203,988
Newly issued common stock shares percentage			100.00%

Investment (Details Narrative)

Investment (Details Narrative)	Dec. 19, 2019SGD ($)shares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2019USD ($)shares
Number of shares owned | shares			21,196,552
Impairment of investment | $		$ 160,000
Stock price has rebounded in excess			15.00%
Investment | $			$ 324,930
Singapore eDevelopment Limited [Member]
Number of shares owned | shares		21,196,552	83,174,129
Warrant term		3 years
Warrant to purchase of common shares | shares		105,982,759	44,005,182
Warrant exercise price per share | $ / shares		$ 0.0298
Total consideration of ordinary shares | $			$ 1,833,000
Outstanding shares, percentage			7.10%
Singapore eDevelopment Limited [Member] | Singapore, Dollars [Member]
Warrant exercise price per share | $ / shares		$ 0.040
Warrant expiration date		Sep. 17, 2019
Number of ordinary shares acquired | shares	61,977,577
Total consideration of ordinary shares | $	$ 2,479,103

Property Plant and Equipment -

Property Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Total cost	$ 11,899,788	$ 10,873,951
Less accumulated depreciation	6,839,090	5,859,457
Property, plant, and equipment, net	5,060,698	5,014,494
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 8,567,911	7,723,763
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	5 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	10 years
Building and Improvements [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 1,961,544	1,923,027
Property and equipment, estimated useful life	39 years
Land [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 185,000	185,000
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 776,674	760,286
Leasehold Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	3 years
Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	10 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 109,862	94,364
Property and equipment, estimated useful life	7 years
Software and Websites [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 298,797	$ 187,511
Property and equipment, estimated useful life	3 years

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	Mar. 05, 2019	Oct. 24, 2018	Jul. 31, 2018	Jun. 26, 2018	Dec. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Patent prosecution costs					$ 10,000	$ 20,000
Amortization expense					461,000	487,000
Payments to acquire intangible assets					(369,735)	(100,138)
Number of shares issued value					7,303,689	1,175,755
Aggregate cost of intangible assets					$ 934,765	$ 881,411
Non-Compete Letter Agreement [Member] | Former President and Chief Executive Officer [Member]
Goodwill [Line Items]
Payment of intangible assets per month			$ 16,000
Amortization expense			$ 304,000
Agreement description			The Agreement called for payments of $16,000 per month, for a period of 19 months, as consideration for the two-year non-competition and non-solicitation restrictive covenants. The Company recorded the aggregate cost of the Agreement of $304,000 as an intangible asset to be amortized over the 24-month period commencing August 1, 2018.
Fortress Credit Co LLC [Member]
Goodwill [Line Items]
Written down of intangible asset				$ 2,655,000
Unamortized debt issuance costs				$ 295,470
Guangzhou Hotapps Technology Ltd [Member]
Goodwill [Line Items]
Agreement description		Guangzhou Hotapps Technology Ltd., ("Guangzhou Hotapps") a Chinese company, in exchange for a 2-year, $100,000 unsecured promissory note. In connection with this acquisition, the Company acquired the license to do business in China to which the Company allocated a value of $85,734 as well as a related deferred tax liability of $33,333 due to outside basis differences and recorded as an intangible asset that it will amortize over a five-year period.
Payments to acquire intangible assets		$ 33,333
Unsecured promissory note		100,000
Deferred tax liability		$ 85,734
Advanced Cyber Security Corp [Member] | Master Distributor Agreement [Member]
Goodwill [Line Items]
Payments to acquire intangible assets	$ 350,000
Number of common stock shares issues	130,435
Number of shares issued value	$ 144,783
Aggregate cost of intangible assets	$ 494,783
Amortization period of intangible asset	36 months

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 3,466,875	$ 2,952,220
Accumulated Amortization		2,532,110	2,070,809
Net Carrying Amount		934,765	881,411
Customer Lists, Licenses and Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		1,788,699	1,284,065
Accumulated Amortization		1,202,832	823,884
Net Carrying Amount		$ 585,867	460,181
Customer Lists, Licenses and Non-compete Agreements [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life		2 years
Customer Lists, Licenses and Non-compete Agreements [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life		10 years
Patent Application Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Useful life, description	[1]	Varied
Gross Carrying Amount		$ 1,178,176	1,168,155
Accumulated Amortization		829,278	746,925
Net Carrying Amount		348,898	421,230
Patents and Patent Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		500,000	500,000
Accumulated Amortization		500,000	500,000
Net Carrying Amount
[1]	Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2019, the weighted average remaining useful life of these assets in service was approximately 6.9 years.

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Intangible Assets (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2019
Patent Application Costs [Member]
Weighted average remaining useful life	6 years 10 months 25 days

Intangible Assets - Schedule _3

Intangible Assets - Schedule of Estimated Future Amortization of Intangible Assets (Details)	Dec. 31, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 383,276
2021	273,626
2022	127,408
2023	39,378
2024	$ 19,112

Short-Term and Long-Term Debt (

Short-Term and Long-Term Debt (Details Narrative) - USD ($)

Jun. 27, 2019

May 31, 2019

Mar. 30, 2019

Feb. 18, 2019

Oct. 24, 2018

Jun. 26, 2018

Apr. 28, 2015

Feb. 13, 2014

Aug. 30, 2011

May 31, 2014

Dec. 31, 2019

Dec. 31, 2018

Dec. 02, 2017

Jul. 26, 2017

Dec. 06, 2013

Debt Instrument [Line Items]

Monthly payments

$ 82,451

Common stock par value

$ .02

$ .02

Gain of extinguishment of liabilities

$ 3,532,659

Two Term Notes [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Nov. 30, 2023

Debt interest rate

5.37%

Monthly payments

$ 13,657

Debt instrument, face amount

576,946

684,554

Promissory Notes [Member]

Debt Instrument [Line Items]

Purchase price for Real Estate acquired

$ 1,500,000

Purchase price for Real Estate acquired, loan obtained

1,200,000

Non Revolving Line of Credit Agreement [Member] | Citizens [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing amount

898,762

339,000

$ 1,200,000

Debt interest rate

2.00%

Monthly payments

12,756

Non Revolving Line of Credit Agreement [Member] | Citizens Bank [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing amount

$ 800,000

Debt interest rate

2.00%

Citizens Bank [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing amount

$ 800,000

Interest rate additional rate above LIBOR

4.50%

Debt instrument, maturity date

May 31, 2020

Credit facility, amount outstanding

$ 500,000

0

Citizens Bank [Member] | Two Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Jun. 27, 2029

Debt interest rate

4.22%

Monthly payments

$ 7,181

Debt instrument, face amount

1,156,742

$ 1,141,487

Debt instrument, final balloon payment

$ 707,689

Citizens Bank [Member] | Refinanced Note One [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

869,865

Citizens Bank [Member] | Refinanced Note Two [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

315,000

Citizens Bank [Member] | Promissory Notes [Member]

Debt Instrument [Line Items]

Monthly payments

$ 7,658

Citizens Bank [Member] | Permanent Loan [Member]

Debt Instrument [Line Items]

Monthly payments

$ 450,000

Debt instrument, term

5 years

Debt instrument maturity date, description

The note was set to matures in July 2019 at which time a balloon payment of the remaining principal balance of $300,000 was due.

Interest accrued in the period

$ 2,500

Debt instrument, final balloon payment

$ 300,000

Citizens Bank [Member] | Permanent Loan [Member] | Maximum [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 450,000

Citizens Bank [Member] | LIBOR [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

2.00%

Citizens Bank [Member] | LIBOR [Member] | Promissory Notes [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

3.15%

Citizens Bank [Member] | LIBOR [Member] | Permanent Loan [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

3.15%

Citizens [Member] | Term Loan [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Apr. 28, 2020

Debt instrument, carrying amount

$ 525,000

$ 39,294

149,542

Debt instrument, term

60 months

Interest rate on outstanding term loan

3.62%

Credit facility agreement, monthly principal payment

$ 9,591

Guangzhou Hotapps Technology Ltd [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Oct. 24, 2020

Unsecured promissory note

$ 100,000

LiquidValue Development Pte Ltd [Member] | Convertible Promissory Note [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Jul. 31, 2019

Debt interest rate

8.00%

Debt instrument, face amount

$ 650,000

$ 500,000

Debt instrument, term

12 months

Debt instrument maturity date, description

Accrued interest was payable in cash in arrears on the last day of each calendar quarter, with the first interest payment due on June 30, 2019, and remains payable until the Principal Amount is paid in full.

Common stock par value

$ 0.02

Debt conversion price per share

$ 1.12

LiquidValue Development Pte Ltd [Member] | Convertible Promissory Note [Member] | Maximum [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

$ 500,000

Debt conversion into common stock

446,428

DSS Technology Management [Member] | Investment Agreement [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

$ 3,714,129

Credit facility agreement, monthly principal payment

345,000

Advances

$ 4,500,000

Deposits

600,000

Repayment of shot term debt

345,000

Gain of extinguishment of liabilities

3,372,129

3,532,659

Fixed and contingent equity interests

459,000

Unamortized debt issuance costs

2,655,000

Unamortized carrying amount of intangible asset

$ 295,470

Balance of term loan

$ 0

Short Term and Long-Term Debt -

Short Term and Long-Term Debt - Schedule of Notes Payable and Long-Term Debt (Details)	Dec. 31, 2019USD ($)
Debt Disclosure [Abstract]
2020	$ 440,699
2021	307,324
2022	322,160
2023	322,926
2024	185,218
Thereafter	$ 1,186,387

Other Liabilities (Details Narr

Other Liabilities (Details Narrative) - USD ($)	Nov. 14, 2016	Jul. 08, 2013	Mar. 31, 2018	Jul. 31, 2017	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Payment to acquire intangible assets						$ 369,735	$ 100,138
Intangible assets book value					$ 2,952,220	3,466,875	2,952,220
Other liabilities short term					2,255,942	390,494	2,255,942
Selling, general and administrative costs						8,283,266	7,088,610
Reduction of the liability						955,000
Current liabilities					5,423,206	4,155,825	5,423,206
LED Patent Portfolio [Member]
Selling, general and administrative costs			$ 80,000	$ 47,500	86,500
DSS Technology Management [Member]
Payment to acquire intangible assets		$ 500,000
Proceeds from financing amount		250,000
Payment milestones amount		$ 750,000
Milestones description		Subject to certain payment milestones, in exchange for 40% of the proceeds which it receives, if any, from the use, sale or licensing of the two patents.
Reduction the liability pays legal and other expense percentage		50.00%
Proceeds Investment Agreement [Member] | Brickell Key Investments LP [Member]
Finance amount	$ 13,500,000
Other liabilities						780,988
Other liabilities short term						390,494
Payment of estimated future inter parts review costs						2,500,000
Payment of related party cost						1,500,000
Proceeds Investment Agreement [Member] | Intellectual Discovery Co. Ltd [Member] | LED Patent Portfolio [Member]
Payment to acquire intangible assets	3,000,000
Intangible assets book value	0
Attorneys' fees and out-of-pocket expenses	6,000,000
Proceeds from financing amount	$ 4,500,000
Proceed Right Agreement [Member] | Investors [Member]
Proceeds from related party debt						750,000	750,000
Current liabilities					$ 476,000	$ 0	$ 476,000

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)

Dec. 09, 2019

Nov. 02, 2019

Sep. 06, 2019

Jul. 18, 2019

Jun. 05, 2019

Mar. 05, 2019

Feb. 18, 2019

Dec. 17, 2018

Jul. 03, 2018

Jun. 20, 2013

Jul. 30, 2019

Dec. 31, 2019

Dec. 31, 2018

May 31, 2019

Common stock par value

$ .02

$ .02

Proceeds from sale of stock

$ 6,658,906

$ 887,755

Share issued price per shares

$ 0.50

Common stock shares exercised

519,186

Proceeds from net offering

$ 5,000,000

Stock compensation expense

$ 422,000

Stock compensation expense, description

The Company had stock compensation expense of approximately $422,000 or less than $0.01 basic and diluted earnings per share ($132,000, or less than $0.01 basic and diluted earnings per share for the corresponding twelve months ended December 31, 2018). Of the $422,000, $114,500 was accrued for the CEO of a subsidiary of the Company.

Number of stock option granted

405,000

Restricted Stock [Member]

Number of restricted common stock issued

224,310

Restricted shares lockup period

2 years

Restricted stock, value

$ 94,000

Stock Options [Member] | 2013 Plan [Member]

Number of stock option granted

1,500,000

Stock Options [Member] | 2020 Plan [Member]

Number of stock option granted

7,236,125

Stock Options [Member]

Number of stock option granted

405,000

Share-based payment award, award service period

5 years

Fair value of options vested during year

$ 104,000

$ 122,000

Stock Options [Member] | First Anniversary [Member]

Number of stock option granted

265,000

Stock Options [Member] | Second Anniversary [Member]

Number of stock option granted

140,000

Maximum [Member] | Stock Options [Member]

Options price per share

$ 1.55

Minimum [Member] | Stock Options [Member]

Options price per share

$ 1.30

LiquidValue Development Pte Ltd [Member] | Convertible Promissory Note [Member]

Common stock par value

$ 0.02

Debt instrument, face amount

$ 500,000

$ 650,000

Debt conversion price per share

$ 1.12

LiquidValue Development Pte Ltd [Member] | Convertible Promissory Note [Member] | Maximum [Member]

Debt instrument, face amount

$ 500,000

Debt conversion into common stock

446,428

Advanced Cyber Security Corp [Member] | Licensing and Distribution Agreement [Member]

Number of shares of common stock, sold

130,435

Purchase price per share

$ 1.15

Aegis Capital Corp [Member] | Underwriting Agreement Member]

Number of common stock shares issues

11,200,000

Share issued price per shares

$ 0.02

Option to purchase shares of common stock

2,000,000

Aegis Capital Corp [Member] | Underwriting Agreement Member] | Public Offering [Member]

Share issued price per shares

$ 0.50

Aegis Capital Corp [Member] | Maximum [Member] | Underwriting Agreement Member]

Option to purchase shares of common stock

1,680,000

Related Party Accredited Investor [Member]

Number of shares of common stock, sold

612,245

214,286

Common stock par value

$ 0.02

$ 0.02

Purchase price per share

$ 0.98

$ 1.40

Proceeds from sale of stock

$ 600,000

$ 300,000

Mr. Heng Fai Ambrose Chan [Member] | LiquidValue Development Pte Ltd [Member] | Subscription Agreement [Member] | Private Placement [Member]

Number of shares of common stock, sold

6,000,000

Purchase price per share

$ 0.30

Closing stock price per share

$ 0.26

Proceeds from issuance of common stock

$ 1,600,000

President - DSS International Business Operations [Member]

Accrued stock based compensation

$ 114,500

Officers and Directors [Member] | 2013 Employee, Director and Consultant Equity Incentive Plan [Member]

Share issued price per shares

$ 0.42

Number of stock issued to stock grants

458,719

Restricted shares lockup period

2 years

Number of restricted stock vested during period

224,310

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Outstanding, Beginning balance	1,430,116	2,645,090
Granted during the year
Lapsed/terminated	(209,812)	(1,214,974)
Outstanding, Ending balance	1,220,304	1,430,116
Exercisable, Ending balance	1,220,304	1,430,116
Outstanding Beginning balance, Weighted Average Exercise Price	$ 4	$ 10.98
Granted, Weighted Average Exercise Price
Lapsed/terminated Weighted Average Exercise Price	20.78	19.20
Outstanding, Ending balance, Weighted Average Exercise Price	1.12	4
Exercisable Weighted Average Exercise Price	1.12	4
Weighted average months remaining	$ 20.7	$ 27.9

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity Under Stock Option and Incentive Plans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Equity [Abstract]
Outstanding, Beginning balance	782,655	482,667
Granted		405,000
Lapsed/terminated	(204,738)	(105,012)
Outstanding, Ending balance	577,917	782,655
Exercisable	408,750	490,988
Expected to vest , Ending balance	169,167	291,667
Outstanding Beginning balance, Weighted Average Exercise Price	$ 6.66	$ 10.72
Granted, Weighted Average Exercise Price		1.38
Lapsed/terminated, Weighted Average Exercise Price		4.96
Outstanding, Ending balance, Weighted Average Exercise Price	5.01	6.66
Exercisable Weighted Average Exercise Price	6.50	8.30
Expected to Vest, Ending balance, Weighted Average Exercise Price	$ 1.43	$ 1.41
Outstanding, Weighted Average Life Remaining	3 years 2 months 12 days	3 years 2 months 12 days
Exercisable, Weighted Average Life Remaining	3 years 6 months	2 years 9 months 18 days
Expected to vest, Weighted Average Life Remaining	3 years 4 months 24 days	4 years 6 months
Aggregate intrinsic value of outstanding option, Ending balance
Aggregate intrinsic value of exercisable options, Ending balance
Aggregate intrinsic value of options expected to vest, Ending balance

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Assumptions Used to Compute the Share-based Compensation Expense for Stock Options and Warrants (Details)	12 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Volatility	98.60%
Expected option term	3 years 7 months 6 days
Risk-free interest rate	2.70%
Expected forfeiture rate	0.00%
Expected dividend yield	0.00%

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Deferred tax assets	$ 46,601
Net operating loss carryforwards	50,600,000
Available to reduce future taxable income	$ 3,800,000
Net operating loss carryforwards, expiration date	2022 through 2039
Deferred tax assets valuation allowance	$ 484,000
Interest and penalties
After December 31, 2017 and Before December 31, 2020 [Member]
Federal tax credit	50.00%

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Provision (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Federal, Current
State, Current	(68)	6,920
Total currently payable	(68)	6,920
Federal, Deferred	(367,473)	458,446
State, Deferred	(124,975)	67,451
Foreign, Deferred	(116,863)	(92,690)
Total deferred	(609,311)	433,207
Less: increase in allowance	476,972	(423,534)
Net deferred	(125,419)	9,673
Total income tax provision	$ (125,487)	$ 16,593

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Deferred tax assets: Net operating loss carryforwards	$ 11,188,858	$ 10,135,005
Deferred tax assets: Equity issued for services	169,445	152,240
Deferred tax assets: Goodwill and other intangibles	675,885	788,288
Deferred tax assets: Investment in pass-through entity	11,621	11,499
Deferred tax assets: Deferred revenue	181,519	472,466
Deferred tax assets: Operating Lease Liability	284,193
Deferred tax assets: Other	376,462	470,780
Deferred tax assets: Gross deferred tax assets	12,887,983	12,030,278
Deferred tax liabilities: Goodwill and other intangibles	29,046	33,333
Deferred tax liabilities: Depreciation and amortization		31,512
Deferred tax liabilities: Right-of-use asset	284,193
Deferred tax liabilities: Gross deferred tax liabilities	313,239	64,845
Deferred tax liabilities: Less: valuation allowance	(12,618,311)	(12,134,419)
Deferred tax liabilities: Net deferred tax liabilities	$ (43,567)	$ (168,986)

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Statutory United States federal rate	21.00%	21.00%
State income taxes net of federal benefit	3.28%	4.00%
Permanent differences	(1.61%)	2.20%
Other	(1.24%)	0.70%
Foreign taxes	(1.09%)	1.70%
Change in valuation reserves	(16.34%)	(28.50%)
Effective rate	4.00%	1.10%

Defined Contribution Pension _2

Defined Contribution Pension Plan (Details Narrative) - USD ($)	Jan. 02, 2019	Dec. 31, 2019	Dec. 31, 2018
Employee's contribution maximum percentage	100.00%
Employer match percentage	1.00%
Contributions by company		$ 123,000	$ 136,000
Additional Contribution [Member]
Employee's contribution maximum percentage	50.00%
Employer match percentage	3.50%

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)	Apr. 30, 2019	Dec. 31, 2019
Rent expense		$ 474,000
Severance payment amount		$ 255,000
Description on employee agreement		The Company has employment or severance agreements with members of its management team with terms no longer than twelve months. The employment or severance agreements provide for severance payments in the event of termination for certain causes. As of December 31, 2019, the minimum severance payments under these employment agreements are, in aggregate, approximately $255,000.
Jeffrey Ronaldi [Member] | 2017 Employment Agreement [Member]
Due to related parties	$ 100,000
Unreimbursed expenses	$ 91,000
Performance bonus percentage	15.00%
Minimum [Member]
Operating lease term		1 year
Maximum [Member]
Operating lease term		4 years

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
2020	$ 396,678
2021	304,669
2022	289,997
2023	269,913
2024	21,860
Total lease payments	1,283,117
Less imputed interest	(60,375)
Present value of remaining lease payments	1,222,742
Current	397,097
Non-current	$ 825,645
Weighted -average remaining lease term (years)	4 years
Weighted average discount rate	5.40%

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 157,000	$ 133,000
Impact of adoption of lease accounting standards	1,568,000
Gain from change in fair value of interest rate swap derivatives	7,000	16,000
Common stock issued upon conversion of convertible note	500,000
Equity issued to purchase intangible assets	145,000
Elimination of contingent liabilities through agreement		459,000
Purchase of intangible assets to be paid in installments		304,000
Purchase of intangible assets with term note inclusive of tax		$ 119,065

Segment Information (Details Na

Segment Information (Details Narrative) - Integer	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Number of operating segment	4
International Revenue [Member]
Segment Reporting Information [Line Items]
Concentration of credit risk, percentage	2.00%	3.40%

Segment Information - Schedule

Segment Information - Schedule of Operations by Reportable Segment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Revenue	$ 19,409,230	$ 18,515,082
Depreciation and amortization	1,403,836	1,281,634
Stock based compensation	421,673	131,733
Income tax expense (benefit)	(125,487)	16,593
Net Income (loss)	(2,889,147)	1,464,969
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	19,409,000	18,515,000
Depreciation and amortization	1,404,000	1,282,000
Interest expense	157,000	(145,000)
Amortized Debt Discount	2,000	(46,000)
Stock based compensation	422,000	132,000
Income tax expense (benefit)	(125,000)	17,000
Net Income (loss)	(2,889,000)	1,465,000
Capital Expenditures	989,000	1,003,000
Identifiable assets	20,145,000	15,280,000
Operating Segments [Member] | Packaging and Printing [Member]
Segment Reporting Information [Line Items]
Revenue	13,230,000	12,957,000
Depreciation and amortization	904,000	775,000
Interest expense	96,000	(89,000)
Amortized Debt Discount	2,000	(2,000)
Stock based compensation	17,000	6,000
Income tax expense (benefit)
Net Income (loss)	311,000	785,000
Capital Expenditures	819,000	643,000
Identifiable assets	10,425,000	9,643,000
Operating Segments [Member] | Plastics [Member]
Segment Reporting Information [Line Items]
Revenue	3,860,000	3,983,000
Depreciation and amortization	253,000	159,000
Interest expense	32,000	(24,000)
Amortized Debt Discount
Stock based compensation
Income tax expense (benefit)
Net Income (loss)	(294,000)	28,000
Capital Expenditures	42,000	305,000
Identifiable assets	3,934,000	3,492,000
Operating Segments [Member] | Digital [Member]
Segment Reporting Information [Line Items]
Revenue	2,147,000	1,543,000
Depreciation and amortization	33,000	8,000
Interest expense	7,000
Amortized Debt Discount
Stock based compensation	81,000	99,000
Income tax expense (benefit)
Net Income (loss)	(579,000)	(1,267,000)
Capital Expenditures	24,000	54,000
Identifiable assets	924,000	955,000
Operating Segments [Member] | Technology Management [Member]
Segment Reporting Information [Line Items]
Revenue		32,000
Depreciation and amortization	82,000	338,000
Interest expense		(13,000)
Amortized Debt Discount		(22,000)
Stock based compensation
Income tax expense (benefit)
Net Income (loss)	(475,000)	3,028,000
Capital Expenditures
Identifiable assets	58,000	130,000
Operating Segments [Member] | Corporate [Member]
Segment Reporting Information [Line Items]
Revenue	172,000
Depreciation and amortization	132,000	2,000
Interest expense	22,000	(19,000)
Amortized Debt Discount		(22,000)
Stock based compensation	324,000	27,000
Income tax expense (benefit)	(125,000)	17,000
Net Income (loss)	(1,852,000)	(1,109,000)
Capital Expenditures	104,000	1,000
Identifiable assets	$ 4,804,000	$ 1,060,000

Segment Information - Schedul_2

Segment Information - Schedule of Disaggregation of Revenue (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Total Printed Products	$ 17,089,000	$ 16,940,000
Total Technology Sales, Services and Licensing	2,148,000	1,575,000
Packaging Printing and Fabrication [Member]
Segment Reporting Information [Line Items]
Total Printed Products	12,307,000	11,741,000
Commercial and Security Printing [Member]
Segment Reporting Information [Line Items]
Total Printed Products	1,159,000	1,241,000
Technology Integrated Plastic Cards and Badges [Member]
Segment Reporting Information [Line Items]
Total Printed Products	1,262,000	1,354,000
Plastic Cards, Badges and Accessories [Member]
Segment Reporting Information [Line Items]
Total Printed Products	2,361,000	2,604,000
Information Technology Sales and Services [Member]
Segment Reporting Information [Line Items]
Total Technology Sales, Services and Licensing	189,000	345,000
Digital Authentication Products and Services [Member]
Segment Reporting Information [Line Items]
Total Technology Sales, Services and Licensing	1,414,000	772,000
Royalties from Licensees [Member]
Segment Reporting Information [Line Items]
Total Technology Sales, Services and Licensing	$ 545,000	$ 458,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Mar. 12, 2020	Mar. 03, 2020	Feb. 25, 2020	Jul. 18, 2019	Jan. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Mar. 30, 2020
Common stock, par value						$ .02	$ .02
Shares issued price per share				$ 0.50
Value of common stock shares issues						$ 7,303,689	$ 1,175,755
Proceeds from offering (inclusive of the over-allotment exercise)				$ 5,000,000
Common Stock [Member]
Number of common stock shares issues						18,296,049	826,531
Value of common stock shares issues						$ 365,921	$ 16,530
Subsequent Event [Member]
Number of common stock shares issues			25,555,556
Shares issued price per share			$ 0.18
Proceeds from offering (inclusive of the over-allotment exercise)			$ 4,000,000
Ownership percentage description					The Company chose to forego the optional conversion of the outstanding principal and interest into 75% ownership and 100% ownership, respectively, as was allowed in the terms of both agreements.
Subsequent Event [Member] | Mr. Heng Fai Ambrose Chan [Member]
Number of common stock shares issues			11,111,112
Value of common stock shares issues			$ 2,000,000
Subsequent Event [Member] | CEO [Member]
Equity ownership percentage								10.00%
Invested amount								$ 460,000
Subsequent Event [Member] | Common Stock [Member]
Number of common stock shares issues			22,222,223
Subsequent Event [Member] | Additional Shares [Member]
Number of common stock shares issues			3,333,333
Subsequent Event [Member] | Term Sheet [Member] | LiquidValue Asset Management Pte Ltd [Member]
Equity ownership percentage		35.00%
Subsequent Event [Member] | Term Sheet [Member] | American Medical REIT Inc. [Member]
Equity ownership percentage		12.50%
Promissory note principal amount		$ 800,000
Note maturity date		Mar. 3, 2022
Note interest rate per annum		8.00%
Number of warrant to purchase shares of common stock		160,000
Warrant exercise price per share		$ 5
Warrant expiration date		Mar. 3, 2024
Subsequent Event [Member] | Term Sheet [Member] | Biohealth Security Technologies [Member]
Purchase price of share exchange transaction	$ 50,000,000
Percentage of consideration	100.00%
Number of common stock shares issues	14,500,000
Common stock, par value	$ 0.02
Shares issued price per share	$ 0.216
Value of common stock shares issues	$ 313,200
Subsequent Event [Member] | Term Sheet [Member] | Global BioMedical Pte Ltd [Member]
Percentage of blocker based issued outstanding shares	19.90%
Subsequent Event [Member] | Term Sheet [Member] | Global BioMedical Pte Ltd [Member] | Singapore eDevelopment Limited [Member]
Equity ownership percentage	100.00%
Subsequent Event [Member] | Term Sheet [Member] | AMRE Asset Management Inc. [Member]
Common stock, par value		$ 0.01
Equity ownership percentage		52.50%
Number of ordinary shares subscribed		5,250
Value of ordinary shares subscribed		$ 53
Subsequent Event [Member] | Term Sheet [Member] | AMRE Asset Management Inc. [Member] | LiquidValue Asset Management Pte Ltd [Member]
Number of common stock shares issues		2,500
Subsequent Event [Member] | Term Sheet [Member] | AMRE Asset Management Inc. [Member] | AMRE Tennessee, LLC [Member]
Number of common stock shares issues		1,250
Subsequent Event [Member] | Term Sheet [Member] | AMRE Asset Management Inc. [Member] | American Medical REIT Inc. [Member]
Number of common stock shares issues		1,250